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CHAPTER I. GENERAL INTRODUCTION 
Introduction 
Conjugated linoleic acid (CLA) is a mixture of positional (9.11; 10,12; or 11,13) and 
geometric (cis or trans) isomers of octadecadienoic (18:2) acid (Ip et al., 1991). Bartlet et al. 
(1961) reported that CLA was an intermediate compound in the microbial biohydrogenation 
of linoleic acid to oleic acid. Kepler et al. (1966) described that an intermediate of the 
biochemical pathway of biohydrogenation catalyzed by the ruminal bacteria Butyrivibrio 
fihrisohens is the CLA isomer cis-9. trans-11. Thus, B. fihrisolvens converts dietary linoleic 
acid into oleic acid, which is the first step towards the synthesis of stearic acid. Once oleic 
acid is synthesized, a different group of bacteria will convert it into stearic acid. Furthermore, 
Chin et al. (1991) studied a partially purified isomerase (linoleate isomerase) from B. 
fihrisolvens and found that most of the added linoleic acid in hydrolyzed saffloweroil was 
converted into CLA. Therefore, linoleate isomerase is the enzyme expressed by B. 
fihrisolvens, which converts linoleic acid into the cis-9, trans-11 isomer of CLA. 
In 1976. Hansen and Czochanska described that fats from pasture-fed lambs contain 
0.1 to 0.7% of cis-9. trans-11-octadecadienoic acid. As a consequence of being produced by a 
ruminal bacteria, CLA is found in a greater concentration in ruminant-derived than in non-
ruminant-derived products (Chin et al.. 1992), including ruminant processed products such as 
cheese (Santha et al.. 1992). Nonruminant products will also contain CLA because of the 
conversion of free linoleic acid by intestinal gram positive bacteria (Chin et al., 1993; Yang 
et al.. 1995). Furthermore. Brown and Moore (1960) isolated strains of B. fihrisolvens in 
human fecal material. Even plant oils contain trace amounts of CLA (Ackman et al., 1981; 
Brown et al.. 1982). Animal sources are richer in CLA than plant sources and, in general. 
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foods from ruminants contain more CLA than foods from nonruminants (Werner et al.. 1992; 
Chinetal.. 1991) (Table 1). 
Until the late 1980s the biological properties of CLA were not known. In 1978. M. 
W. Pariza and colleagues at the University of Wisconsin at Madison began to investigate 
possible mutagen formation in meat during cooking, a research objective that, initially, did 
not seem to be directly related to CLA. Instead, a beef-derived mutagen inhibitor was 
Table 1. CLA content in the fat of foods 
Food mg of CLA / g of fat % of cis9. trans 11 in CLA 
Ruminant veal 
Lamb 
Pork and chicken 
Eggs 
Turkey 
Processed turkey or beef 
Milk 
Romana cheese 
Colby cheese 
Peanut and com oil 
Safflower oil 
2.7 
5.6 
0.5 to 0.9 
2.5 
1.6 to 3.8 
75 
75 
75 
75 
75 
30 (Parodi. 1996) 2.4-18 (Griinari et al.. 1995) 
2.9 75 
6.1 
0.2 
0.7 
75 
<50 
<50 
Adapted from Chin et al.. 1991. 
* Only trace amounts of CLA were detected. 
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discovered (Pariza et al.. 1985). In 1987. Ha, Grimm and Pariza identified that mutagen 
inhibitor. They became the first research team that described the anticarcinogenic properties 
of CLA. This was the beginning of modem CLA research. Since 1987. subsequent 
investigations have allowed scientists to ftirther characterize the biological properties of this 
compound. CLA was shown to be anticarcinogenic (Ha et al.. 1989: Ha et al.. 1990; Pariza, 
1991 :Shultz et al.. 1992a; Shultz et al.. 1992b; Ip et al.. 1994a; Ip et al.. 1994b; Ip et al., 
1994c; Ip et al.. 1997: and Liu et al.. 1997), antidiabetic (Houseknecht et al., 1998), 
antiatherogenic (Nicolosi et al.. 1993: Lee et al., 1994) and immunomodulator (Ip et al.. 
1991; Cook et al.. 1993: Miller etal.. 1994; Wongetal.. 1997: Chew et al.. 1997: 
Bassaganya-Riera et al.. 1998; Sugano et al.. 1998: Bassaganya-Riera et al.. 1999; and Hayek 
et al.. 1999). Although it was initially reported that CLA was an antioxidant (Ha et al., 1990), 
based on its stnicture. it was inferred that there is no chemical evidence that CLA could be an 
effective antio.xidant (Yurawecz et al.. 1995). Finally. Van den Berg et al. (1995) confirmed 
the previous inference by reporting that a role for CLA as an antioxidant does not seem 
plausible because it did not act as an efficient radical scavenger in any way comparable to 
vitamin E or butylated hydroxytoluene (BHT). 
Of the various isomers of CLA the cis-9. trans-11 isomer (Figure I) is preferentially 
incorporated into the membrane phospholipids of mice (Ha et al., 1990) and rats (Ip et al., 
1991). These findings have been the origin of the speculation that cis-9. trans-11 is the 
biologically active isomer. Li et al. (1998) showed that in rats there was tissue selectivity for 
various isomers (e.g., in liver, serum, bone marrow and periosteum c-9. t-11/1-9, c-11 
predominate, whereas in spleen muscle and heart t-10, c-12 predominates). Furthermore they 
reported that CLA c-9. t-11/1-9, c-I I isomers concentrations in bone were the highest of all 
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Figure I. Structural differences between the CLA c-9. t-l I isomer and linoleic acid 
O Q ^ O 
,0 o'- . V 
o  ^  ro, o o  •  •  o *  
O O o • O • 
% 0 0 i *^ 0 
8 • V 
Linoleic acid C-9.t-11 CLA isomer 
tissues analyzed. The tissue selectivity of c-9. t-l l/t-9. c-11 CLA isomers for the bone 
marrow and their subsequent accumulation in that tissue indicates that immune cell 
progenitors are putatively exposed to high concentrations of CLA. 
Kramer et al. (1998) described an accumulation of the 11-cis. 13-U*ans-18:2 into 
cardiac lipids, and in particular into diphosphatidylglycerol (DPG) in the inner mithocondrial 
membrane. This could be due to slower metabolism or preferential incorporation. The 
incorporation of 11-cis. 13-trans-l8:2 into mithocondrial DPG could adversely affect the 
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activity of key enzymes in mithocondrial energetics, because DPG is imbedded in many of 
these enzymes (Hoch. 1992; Shigenaga. 1994). 
Most of the research conducted on CLA has identified phenomena and not 
mechanisms. Nevertheless, an exception to that empirical approach is the work conducted at 
Belury's laboratory at Purdue University where a mechanism of action related to a decrease 
in arachidonic acid (AA) synthesis and eicosanoid production was postulated (Belury et al.. 
1997). Later, when investigating the antidiabetic properties of CLA at a molecular level 
(Houseknecht et al.. 1998). they have suggested that CLA could be a peroxisome 
proliferator-activated receptor gamma (PPAR-y) ligand. During the last 13 years, the 
scientific community has described a large list of effects of CLA but the postulated 
eicosanoid-related mechanism of action does not provide an explanation for all the biological 
effects caused by this compound. The possible existence of a common mechanistic link, 
capable of providing a comprehensive explanation for the distinct biological properties of 
CLA. would require that more CLA research were conducted at the molecular level. In the 
early years of modem CLA research. Ip et al. (1991) and Chin et al. (1994) suggested that a 
major emphasis of future research should be on measuring the action of CLA along signal 
transduction pathways. In the future, scientists conducting CLA research should investigate 
whether PPAR-y-CLA binding in a cell environment with low levels of eicosanoids provides 
a comprehensive explanation for most of the biological properties of CLA. 
As mentioned earlier. CLA properties have been partly related to a fatty acid 
desaturase-related inhibition of the conversion of linoleic acid into AA (Belury et al.. 1997; 
Wong et al.. 1997). CLA causes a decrease in hepatic stearoyl-CoA desaturase mRNA 
expression (Lee et al.. 1998) and. therefore, desaturation from linoleic to AA would occur at 
6  
a slower rate. AA is a precursor for the synthesis of inflammatory mediators like 
prostaglandins (PGs) and leukotrienes (LTs) through cyclooxygenase and lipooxygenase 
activity, respectively. It would be interesting to investigate if that decrease in desaturase 
mRNA expression derives from PPAR-CLA ligation. Thus, by supplementing diets with 
CLA. less AA is synthesized in vivo. As a consequence, unless additional dietary AA is 
provided, eicosanoid synthesis is decreased. Other nutrients have been shown to influence 
AA metabolism and. therefore, to potentially interact with the effects caused by dietary CLA. 
For instance, dietary methionine has been shown to stimulate the metabolic conversion of 
linoleic acid into AA in rats possibly by altering A^'-desaturase activity (Choy et al., 1989; 
Sugiyama et al.. 1997). Vitamin B6-deficient diets caused decreases in both the 
phophatidylcholine (PC)/ phosphatidylethanolamine (PE) ratio and A^-desaturase activity of 
rat liver microsomes (She et al.. 1994). 
.Although, when comparing n-3 mediated and CLA-mediated effects, the final 
immunological outcome is completely different, the eicosanoid-driven phenomenon to 
explain CLA immunmodulatory properties is consistent with the effects described for long 
chain n-3 polyunsaturated fatty acids (PUFA) on AA metabolism, which also inhibit 
eicosanoid production (Huang. 1989; andCalder. 1996). N-3 are the PUFA in which the last 
double bond is located between the third and the fourth carbon from the methyl end of the 
fatty acid chain, whereas, in n-6 PUFA. the last double bond is located between the sixth and 
the seventh carbon from the methyl end of the fatty acid chain. Therefore, some isomers of 
CLA could be considered n-6 (the isomers with the last double bond firom the methyl end of 
the fatty acid chain located in the sixth position; clO, tl2/ tlO, cl2) but not all the other 
isomers, which could be considered either n-5 (cU, tl3/ tl I, cI3) or n-7 (c9. tl 1/ til, c9). As 
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the definition of CLA includes all the isomers. CLA will not be defined as an n-6 PUFA in 
this dissertation. The mechanism of n-3-induced inhibition of eicosanoid production has also 
been used to explain how some PUFA are related to the modulation of inflammation and 
immune function (Goodwin et al., 1983; Hwang. 1989: Kinsella et al.. 1990). 
The differences in structure and function of the immune system between vertebrate 
species suggest that the immunomodulating properties induced by dietary CLA or other 
dietarv' immunomodulators could vary from species to species. The recent development of 
modem immunology has been primarily a story of "Mice and Men" (Pastoret et al., 1998). 
Thus, most of the immunological concepts that are currently accepted to describe how the 
immune system operates have been based on research conducted in humans and inbred mice. 
However, both gaps in the current knowledge of porcine immunology and evolutionary 
divergence (Pastoret et al.. 1998) between swine and humans or mice suggest that 
immunomodulation as described in a particular species, will not necessarily apply in the 
exact same way to other species. Therefore, experimental work on CLA. being a type of 
research involving both nutrition and immune function in pigs should be built on the basis of 
strongly supported species-focused scientific knowledge. Particularly, because the effects of 
dietary nutrients on both immune cell phenotype and immune response are complex 
(Cunnigham-Rundles. 1994). The enhancement in the understanding of the immune system 
of species that are being used as models should be an additional objective, and would 
probably become an obvious consequence of research involving nutrition and immunity. 
The broad range of biological effects caused by CLA makes this compound an ideal 
target for dietar\' immunomodulation research in swine. I hypothesize that dietary CLA will 
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modulate the phenotype and tlmction of cells involved in cell-mediated immunity in pigs and 
that modulation will impact some of the immunological profiles induced by vaccination. 
Objectives of the Dissertation 
The purpose of the research reported in this dissertation was to measure the effects of 
dietary polyunsaturated fatty acids on the immune response. More specifically, it was to 
evaluate the capacity of dietary CLA to modulate cell-mediated immunity in pigs. This 
objective was accomplished by measuring phenotypic and functional characteristics on 
porcine T cell subsets. The effects of CLA on pigs of distinct health status and on pigs with 
different vaccine-induced immunological profiles was also evaluated. 
Dissertation Organization 
This dissertation is organized in four chapters: a General Introduction including a 
literature review, a manuscript to be submitted to the Journal of Animal Science, a 
manuscript to be submitted to the Journal of Immunology, and a General Conclusion. 
Literature Review 
Nutrition and Immune Function 
Background and Precedents of Nutritional Immunomodulation 
Growth, differentiation and reproduction are biological processes inherent to all cell 
types. To successfully accomplish these biological processes cells require seven major 
molecule types: water, amino acids, nucleotides, sugars, fatty acids, vitamins and minerals 
(Voet &. Voet. 1995). These molecules, after adequate processing, provide structure, function 
and energy to cells (Suyer. 1995). In higher organisms, the cooperation between the digestive 
and the circulatory systems make these molecules available to cells (Guyton & Hall, 1996). 
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Nutrients guarantee that the biological processes of cells, tissues, organs and 
organisms can be accomplished. Some decades ago, the recognition of the importance of 
nutrition by the people of developed societies lead to the creation of government policies 
favorable to support public institutions, which compiled nutritional data and made practical 
recommendations. The three most important institutions in the world charged to fulfill that 
purpose are: The Agricultural Research Council (ARC) in the United Kingdom, The National 
Research Council (NRC) in the United States, and L'Institut National de la Recherche 
Agronomique (INRA) in France. In 1967. the ARC defined that the requirement for any 
given nutrient is the amount of that nutrient which must be supplied in the diet to meet the 
needs of the normal healthy animal given an otherwise completely adequate diet in an 
environment compatible with good health. Therefore, by that time nutritionists had realized 
that nutrition and health are two overlapping disciplines the effects of which could be bi­
directional in nature. Today, health status is a criterion that is being used by some swine 
nutritionists to adjust dietary formulations (ISU. 1996). When defining health status from an 
animal perspective, the immune system becomes a key factor that regulates the balance 
between health and disease. 
Immune function becomes an element of decisive importance for the maintenance of 
healdi. Tlius, a better understanding of the existing interactions between nutrition and 
immune function would allow nutritionists to formulate appropriate diets based on the 
particular health status of the animal population. The NRC. the American homonym of the 
British ARC. is also including references to immune function into their periodic revisions of 
the nutrient requirements of domestic animals (Table 2). 
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Table 2. Importance of immune response based on NRC publications 
The nutrient requirements of 
Years Species Nutrients with immunomodulatory effects 
1994 Poultry Vitamin A. pyridoxine. n-3 / n-6 PUFA 
1988 and 1998 Swine Vitamin A. riboflavin, folacin. panthotenate, pyridoxine 
1996 Beef cattle Vitamin A. selenium, zinc, cobalt 
1989 Horses Vitamin A, pyridoxine. vitamin E 
1995 Lab. Animals Vitamin A, folacin. niacin, panthotenate. zinc 
1985 Dogs Vitamin A. folacin 
1993 Fish Vitamin A. vitamin E. vitamin C* 
1989 Dairy cattle Vitamin A 
1981 Goats Vitamin A 
Only were included those nutrients that, based on the respective NRC references, have been 
reported to elicit direct effects on immune response or on cells of the immune system. 
* Indicates that NRC reported that dietary immunomodulation was demostrated to be non­
existent. 
Remarkably noticeable is that the subcommittee on swine nutrition (NRC. 1998) uses 
exactly the same immunological generic terms that were already used by the previous 
subcommittee (NRC. 1988) to discuss the signs of riboflavin, folacin. panthotenic acid and 
pyridoxine deficiency. Does it mean that during a 10-year period additional research 
regarding the impact of these vitamins on immune ftinction was not conducted in swine? It 
could also be infeaed that nutritional immunomodulation during the last century's NRC 
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publications did not occupy a central position in the revision, although there is a clear 
recognition of the importance of health, even when defining nutrient requirement (ARC, 
1967). It is also interesting to notice that Vitamin A effects are consistently observed among 
distinct animal species and reported in all the reviewed NRC publications. 
Nutrient requirements of present-day livestock animals are not the same as when they 
were first domesticated. A strong genetic selection pressure has changed the body 
composition and. therefore, the nutrient requirements of most of the livestock animals. 
Genetic changes induced by humans may also have had an impact on immune cells and on 
immune response of domestic animal species (e.g.. selection for rapid growth may be 
inadvertently linked to selection against disease resistance). In the future, nutritionists should 
formulate diets that both provide the necessary nutrients to allow animals to maximize their 
genetic potential for growth and reproduction, and to induce the type of immune response 
most favorable for the environment they are in and the disease status they have acquired. 
Today, it is clear that small deficiencies of a particular nutrient can induce suppression of the 
cellular and/or the humoral arm of the immune system, but a more severe deficiency must 
occur before its effects can be observed in growth performance. An important question that 
will need to be answered in the coming years is whether the information provided by the 
NRC on nutrition and immune fianction is enough to permit nutritionists to formulate 
immunologically-appropriate diets. Thus, considering that because of the impact of other 
disciplines such as genetics and immunology on animal characteristics, modem nutrition has 
become a multidisciplinary science. Should NRC. ARC and INRA include a chapter on 
nutrition and immune function and another on nutrition and regulation of gene expression in 
their periodic reviews of the nutrient requirements of the domestic animals? 
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In humans and in laboratory animals important immunological concepts have been 
developed at the cellular and molecular level to enhance the understanding of the interaction 
between nutrition and immunology. However, in pigs the study of immunological concepts at 
this basic level is a more immature work. For instance, scientists have described the concept 
of induction of oral tolerance to dietary antigens based on studies conducted in humans and 
mice (Brandtzaeg. 1996). The subtle understanding of oral tolerance at the cellular and 
molecular levels is fundamental to better understand mucosal immunology and also to 
improve the knowledge of the role of CDS'" T cells in the intestine (Sachdev et al., 1993; Li 
et al.. 1995). which might represent between 20 and 40% of lEL ( intraepithelial 
lymphocytes) in swine. Another human- and mice-based concept is how immune cell 
maturation and differentiation occurs. Based on human studies, we know that the immune 
system has particular nutrient requirements, which may vary according to the stage of 
immunologic development (Chandra. 1993). In humans, the immune system is immature at 
birth, evolves and changes over the span of life and may undergo senescence (Cunningham-
Rundles. et al.. 1998). McCoy (1998). using human and murine models, suggested that 
differentiation and maturation of lymphoid cells is highly dependent on the presence and 
function of appropriate enzymes, macronutrients and micronutrients. Are micro- and 
macronutrients for immune cell maturation and differentiation required at the same 
concentrations in swine, humans and mice? To answer that question, scientists should 
probably elucidate first how the nutrient requirements of the immune system relate to the 
dietary requirements of each animal species. 
Dietary PUFA collaborate in the maintenance of membrane structure, fluidity and 
flmction (Calder. 1998). In T cells, membrane dynamics is timdamental for the orchestration 
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of extracellular interactions (Shaw et al., 1997) and for organization of supramolecuiar 
activation clusters (SMACs) or organized contacts of receptor (T-cell receptor; TCR) and 
coreceptor (CD4. CDS. etc.) molecules at the interfaces of physical contact between T cells 
and antigen presenting cells (APCs) (Monks et al., 1998). Thus, these three ftmctions 
together with a possible PP.AR ligation, make PUFAs crucial players in the development of 
the immune response and one of the most important groups of dietary immunomodulators. In 
spite of that, among all the reviewed NR.C publications, only the subcommittee on poultry 
nutrition (Table 1) made a direct reference to their immunomodulating properties. 
CLA. like other natural dietary immunomodulators may become part of the 
nutritional technologies that, during the 21st century, will be applied to enhance the 
efficiency of animal agriculture and to improve human health. CLA immunomodulatory 
technologies should be understood and applied in the context of a potential interaction with 
other nutrients such as vitamin A or other fatty acids. The potential for occurrence of these 
interactions is going to be further discussed at the molecular level in a later discussion. The 
application of a more mechanistic approach in nutritional research will eventually create a 
new science that should be called molecular nutrition. 
Oral Tolerance 
The gastrointestinal mucosa is one of the largest interfaces in the body with only a 
single layer of epithelium separating the exposed e.xtemal lumen from the internal milieu 
(Saito et al.. 1998). When either a food component or a soluble protein immunogen is orally 
administered it will be denatured by hydrochloric acid, degraded by digestive enzymes and 
absorbed into the circulation (Harokopakis et al., 1998). There are exceptions to that 
catabolic pathway e.g.. intact antigens have been shown to cross the normal gut barrier and 
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enter the blood stream, even in adults (Brandtzaeg et al.. 1987). The physiologic importance 
of oral tolerance may be as a means of preventing immune responses to bacteria that 
normally reside as commensals in the intestinal lumen (Abbas et al.. 1997). 
Oral tolerance is a complex down-regulatory phenomenon induced via the 
gastrointestinal tract (Brandtzaeg. 1998). The oral administration of a protein antigen often 
leads to a marked suppression of systemic humoral and cell-mediated immune responses to 
immunization with the same antigen (Abbas et al.. 1997). There are three basic 
immunological mechanisms that could e.xplain the concept of antigen-driven tolerance: 
clonal deletion, clonal anergy. and active suppression by regulatory cells. However, anergy-
driven tolerance (high doses of antigen) and regulatory cell-driven tolerance (low doses of 
antigen) were postulated to be the most probable mechanisms of induction of oral tolerance 
in humans (Weiner et al.. 1994). 
Particularly interesting is the role of CD8^ T cells in oral tolerance. E.Kperiments 
using CD8 knock-out mice concluded that CD8^ T cells are crucial for the downregulation of 
orally elicited mucosal immunity (Homquist et al.. 1996). When enterocytes are used as 
APCs the result has been stimulation of CD8^ T cells with suppressor function (Brandtzaeg 
et al.. 1989). .Also. Harper et al. (1996) showed that murine APCs from intestinal origin 
(lamina propia and Peyer's patches) induced a suppressive type of T cell response, whereas 
when splenic APCs were used. T cell suppression was not observed. Such different responses 
may result from distinctive processing and presentation of the antigen by APCs (Harper et 
al.. 1996). Furthermore. Li et al. (1995) described that human enterocytes e.\press a ligand 
(gpl80) that, by interacting with the alpha chain of CDS. may rapidly activate the tyrosine 
kinase p56''''' (a Src-family kinase which is constitutively associated with the cytoplasmic 
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domain of the coreceptor molecules CD4 and CDS alpha chain (Bolen et al., 1997)), and 
thereby trigger preferentially CDS"^ T cells. 
At the cellular level, the concept of peripheral tolerance, which might play a role on 
induction of oral tolerance, involves the elimination of mature antigen-specific T cells after 
activation to effector function through apoptosis (Von Boehmer et al.. 1997). Are antigen-
specific CD8' T cells eliminated by this mechanism? Those CDS' T cells (CDSaa in pigs) 
that are immunoregulator\' act via secretion of transforming growth factor-p (TGF-P) after 
antigen-specific triggering (Weiner et al.. 1994). E.xpression of certain cyclins and cyclin-
associated proteins such as cyclin-dependent kinases (CDKs) are regulated by specific 
growth factors (Sherr et al.. 1995). As a consequence of the discovery of proteins that bind to 
and inhibit the catalytic activity ofcyclin-CDK comple.xes. kinase inhibition has been 
identified as an intrinsic component of cell cycle control (Peter et al.. 1994; and Sherr et al., 
1995). These cyclin kinase inhibitors (CKIs) induce cell-cycle arrest in response to anti­
proliferative signals, including contact inhibition and serum deprivation (Polyak et al., 1994), 
TGF-P (Reynisdottir et al.. 1995). myeloid (Liu et al.. 1996) and neuronal differentiation 
(Lee et al.. 1996). and DNA-damage checkpoints (El-Deiry et al.. 1993). The identified 
inhibitors have been grouped into two families based on sequence and functional differences 
the INK4 and the Kip/Cip family (Russo et al.. 1996). The Kip/Cip family of inhibitors, 
w h i c h  i n c l u d e  p 2 7 ' ' ' ' ' ' (  P o l y a k  e t  a l . .  1 9 9 4 ;  T o y o s h i m a  e t  a l . .  1 9 9 4 ) .  p 2 1 ( E l - D e i r y  e t  
al.. 1993; Xiong et al.. 1993; Gu et al.. 1993; Harper et al.. 1993). inhibit cyclin-CDK 
complexes with preference for the G1 and S phase over the mitotic phase kinase complexes 
(Russo et al.. 1996). The induction of p27'"''' by TGF-P is an important example of how 
cyclins and cyclin-associated proteins are regulated by specific growth factors (Sherr et al.. 
16  
1995). Thus, the relationship between TGF-P and regulation of cell cycle could also provide 
some insights to how the CD8^ T-induced immunoregulatory process occurs. Swine have a 
large proportion of peripheral T cells that are CD8aa. These cells will recirculate between 
blood and lymphoid tissues such as mesenteric lymph nodes (MLN). Both T and B cells 
found in porcine MLN preferentially home to the gut (Salmon. 1986). Moreover, in the 
porcine gut-associated lymphoid tissue (GALT) CD8aa lEL are also abundant. Is the path of 
some CD8aa: from peripheral blood to MLN and from MLN to GALT or most of the lELs 
and LPLs CD8aa are e.xtrathymic and originated in the GALT? Would these cells elicit 
similar suppressive effects in pigs? 
TCR76 lEL are contrasuppressor cells in mice (Kiyono et al.. 1994). They abrogate 
CD8-driven tolerance. In swine. TCRy6 can be divided into two subpopulations based on 
surface expression of the co-receptor molecule CD8aa; TCRy6CD8aa' cells and TCRyS 
CDSaa" cells, .\dding both populations the result are the TCRy6'. and in swine they 
represent approximately the 35% of peripheral blood mononuclear cells (PBMC). Whereas 
only a maximum of 20% of small intestine-lEL (SI-IEL) are TCRy6" and in the large 
intestine (Ll-IEL) between 10 and 30% of the lymphocytes are TCRy6^ in swine, in mice 
between 20 and 80% of SI-IEL e.xpress TCRy6 (Goodman et al., 1988; Bonneville et al., 
1988). There are. however, similarities between mice and pigs regarding the percentage of 
CDS single positive (CD8 SP) cells in intestinal lEL, In both cases, CDS SP cells are less 
prevalent among Ll-IEL than SI-IEL (Camerini et al., 1993). GALT is an important source of 
peripheral lymphocytes that develop extrathymically. Small cellular clusters called 
cryptopatches. located within the lamina propia of the small intestine, have been shown to 
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contain T cell progenitors that are CD4"CD8'CD3' c-kit positive (c-kit") but lineage marker 
negative (Lin") (Saito et al.. 1998). These progenitor cells are capable of reconstituting 
peripheral and intestinal T cell compartments upon adoptive transfer to immunodeficient 
mice (Saito et al.. 1998). The phenotype of these progenitor cells found in cryptopatches is 
similar to that of a lineage of lymphoid precursors which lack myeloid differentiation 
potential found in the bone marrow (Kondo et al.. 1997). The presence of greater levels of 
TCRy6 cells in the intestine of pigs infected with Brachyspiru hyoclysenteriae. the causative 
agent of swine dysentery (SD). may be correlated to a greater severity in both clinical signs 
and intestinal lesions than pigs with lower levels of intestinal TCR76 (Personnal 
communication of M. J. Wannemuehler). Therefore, oral tolerance could show scientists that 
a dietary-induced manipulation of lEL phenotype together with an inhibition of the intestinal 
inflammatory response could be favorably used to inhibit undesirable immune responses of 
clinical importance such as food hypersensitivity, autoimmune diseases and infectious 
inflammatory diseases in which the immune system is a crucial element in the pathogenesis 
of the disease. 
In piglets, food hypersensitivity is thought to be responsible for some cases of 
postweaning diarrhea and decreased growth performance (Li et al.. 1991; Friesen et al.. 
1993). If oral tolerance occurs etTiciently the undesirable consequences of food 
hypersensitivity such as changes in gut morphology and malabsorption will be suppressed. 
Sugano et al. (1998) found that CLA decreases the production of IgE and suggested that CLA 
mitigates the food-induced allergic reaction. Therefore. CLA could help decrease the 
negative consequences of food hypersensitivity potentially by favorably modifying 
immunological parameters involved in oral tolerance. 
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Dietary Pat and Immune Function 
There are three overlapping phases on lipids and immunomodulation research and 
these three phases can also be identified in CLA research. Meade and Mertin (1978) 
indicated in their review that the interest in the effects of dietary lipids on the immune system 
dates back many years. That review shows that the first phase of immunomodulatory lipid 
research was basically supponed by empirical studies. In a second phase of lipid research, the 
elucidation of the roles of eicosanoids derived from AA in modulating inflammation and 
immunity provided a mechanistic basis to phenomena described in the first phase (Goodwin 
etal.. 1983: Hwang. 1989: and Kinsella et al.. 1990: Roper etal.. 1994). This eicosanoid-
driven research phase has a stronger basis than the empirical research to define phenomena 
based on the mechanism of action. There is a third phase discussed in more detail under; 
Approach to the Molecular Basis of Fatty Acid-induced Immunomodulation. The third phase 
provides the molecular evidence (PPARs) that links dietary fatty acids and regulation of gene 
e.xpression. Currently, scientists should take into consideration the cumulative results, 
methods and approaches derived from all three phases to decode the effects that fatty acids 
elicit on immune response to find ways to induce a fatty acid-derived desired response. In 
light of the current knowledge, the mechanism of action of fatty acid-induced 
immunomodulation is multifactorial and at least both eicosanoid- and PPAR-driven. 
Prostaglandin Ez (PGE:) has been shown to inhibit interleukin-2 (IL-2) production 
(Roitt et al.. 1998). which is instrumental for lymphocyte proliferation and enhances the 
activity of CDS T ceils and NK cells (Kuby. 1997). PGEt was demonstrated to be supressive 
to the cellular arm of the immune system (Gold>'ne and Strobo. 1982). Also, IL-2 deficient 
mice develop disorders of the hemopoietic and immune systems characterized by anemia. 
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lymphocytic hyperplasia, and colitis (Contractor et al.. 1998). Wong et al. (1997) and Hayek 
et al. (1999) showed that dietary CLA increases IL-2 production in lymphocytes isolated 
from spleen of mice. The eicosanoid-based mechanistic explanation for fatty acid-induced 
immunomodulation suggests the existence of an immunomodulatory mechanism of AA 
metabolism modification that for both n-3 PUFA and CLA is related, in part, to the inhibition 
ofeicosanoid production. Both types of PUFA seem to decrease PGE: production (Fritsche et 
al.. 1993; Belury et al.. 1997: Peterson et al.. 1998). However, the final immunomodulatory 
outcome when feeding CLA or n-3 PUF.A. is different. Phenomena derived from feeding 
CLA are related to an enhancement of the immune response (Michal et al.. 1992: Miller et 
al.. 1994: Wong et al.. 1997: Chew et al.. 1997: Bassaganya-Riera et al.. 1998: Sugano et al.. 
1998: Bassaganya-Riera et al.. 1999: Hayek et al.. 1999). Wliereas. phenomena derived from 
feeding n-3 PUF.A. are related to a suppressive type of immune response (Lee et al., 1985: 
Endres et al.. 1989: Virella et al.. 1989: Meydani et al.. 1991: Kelley et al 1992; Jolly et al.. 
1997: Kelley et al.. 1998: Peterson et al.. 1998). These different outcomes can be explained 
because n-3 PUF.A inhibit PGEi production but PGE3 production would be enhanced because 
the n-3 PUFA eicosapentaenoic acid (EPA) gives rise to 3 series PGs and 5 series LTs 
(Calder. 1998). PGE.i is more immunosuppressive than PGEi. When going from PGEi to 
PGE3 there is a stronger inliibition in lymphocyte proliferation (Shapiro et al.. 1993). CLA. 
therefore, would Inhibit PGEi production without giving rise to 3 series PGs. Therefore. 
based on the described influence of type of PG on immune response, the immunological 
impact of dietary CLA supplementation would be greater for swine dietary formulations 
containing fish oil (rich in EPA and docosahexanoic (DHA)) than for diets with lower 
content in n-3 PUFA. 
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There is. however, a particular type of research that has not been pursued in the 
context of fatty acid-induced immunomodulation, which could provide novel and interesting 
information with regard to how dietary fatty acids modulate immune function. As mentioned 
earlier when describing the concept of SMACs. T cell membrane dynamics plays a crucial 
role in the development of the immune response. Shaw and Dustin (1997) indicated that the 
better understanding of protein interactions in membranes is a new frontier in biology and is 
a general area in which the T cell activation system is poised to take the lead. Membrane 
microdomains defined as rafts have been proposed as specialized cell surface platforms used 
for the selective delivery of membrane proteins (Ledesma et al.. 1999). The understanding of 
how protein interactions in T cell membranes can be modulated through nutritional 
technologies capable of altering membrane fluidity in these functionally specialized 
microdomains. particularly by modifying T cell fatty acid composition, would allow for a 
subtle nutritional control of T cell activation. Once a model relating membrane fluidity to 
modulation of immune cell biological responses were established, mixtures of fatty acids and 
of isomers of fatty acids could be prepared in the proportions that provide the membrane 
fluidity necessary to achieve the level of protein interaction, both within and between cells, 
that contributes to optimize particular types of immune responses. 
Natural Dietary Immunomodulators as Alternatives to the Use of Antibiotics 
In the United States, dietary immunomodulation by using natural products is a 
strategy that will be more and more used by producers after antibiotic withdrawal from 
livestock, dietarv' formulations. As long as antimicrobials are allowed tor use in production 
animal diets, bacterial diseases will remain under control because antimicrobials target 
directly the bacteria. However, in the future, consumer concerns, decreased marketability of 
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swine products in foreign countries, and development of antibiotic-resistant human 
pathogens may impose a restriction on use of antimicrobials in livestock diets in the U. S., as 
it has happened in the European Union. The elimination of antimicrobial utilization at 
subtherapeutical doses will increase the likelihood that epidemic outbreaks of bacterial 
diseases occur. In this context, swine dysentery along with other enteric diseases, might 
threaten the productivity of the swine industry. 
CLA and Growth 
Cook et al. (1993) showed that dietary CLA was effective in the prevention of growth 
depression induced by immune stimulation derived from lipopolysaccharide (LPS) injection 
in chicks. In the same article it was reported that similar findings were observed in rats and 
mice. Miller et al. (1994) reported that feeding CLA to mice prevented the severe body 
weight loss caused by LPS injection as observed in mice fed a non-CLA basal diet. However, 
pigs were not used as a model in this initial work conducted at the University of Wiconsin at 
Madison. Chin et al. (1994) fed CLA to rat dams during gestation and lactation. Data indicate 
that pups from dams receiving CLA during gestation and lactation were heavier than pups 
from control dams. 
In weaning pigs. CLA improves feed efficiency but not average daily gain 
(Bassaganya-Riera et al.. 1999). CLA tended to increase feed efficiency in finisher gilts 
(Dunshea et al.. 1998). Sparks et al. (1999) showed a quadratic increase in feed efficiency in 
response to dietary CLA in grower-finisher pigs. However. Eggert et al. (1999) indicate that 
feed efficiency was not affected by feeding CLA to two genotypes of lean gilts. Thus, the 
effects of CLA on feed efficiency are not consistent fi-om one experiment to the other. The 
quality of the source of CLA used, the composition of the basal diet, health status, and the 
environmental conditions in which the experiment is held are variables that could potentially 
influence the final outcome. 
CLA and Immune Response 
As shown on CLA and growth. CLA does not improve growth unless in the context 
of changes in immune or inflammatory profiles. Thus, the benefits of CLA on growth might 
be caused by both an enhancement in the immune response and a decrease in the undesirable 
consequences of inflammation. 
With regard to the effects of CLA on the immune response, both Wong et al. (1997) 
and Hayek et al. (1999) showed that interleukin-2 (lL-2) production in splenic lymphocytes 
was enhanced in response to dietary CLA in mice. IL-2 is a cytokine also called T-cell 
growth factor produced by activated T cells that enhances proliferation and differentiation of 
most of the lymphocyte subpopulations (Abbas et al., 1997). Thus, increase in lL-2 
production in response to dietar\' CLA would be consistent with enhancement in percentage 
of CDS" T cells in pigs described by Bassaganya-Riera et al. (1999). 
However. Chew et al (1997). and Michal et al. (1992) described in porcine PBMC 
that CLA decreased lL-2 production in vitro. The experiments indicating enhancement of IL-
2 production in response to CLA were conducted in vivo, whereas the experiments indicating 
a decrease in lL-2 production were conducted in vitro. A possible explanation for that 
inconsistency in CLA effects is that CLA added directly into cell cultures could become toxic 
for cells. Chew et al (1997) and Michal et al. (1992) did not investigate if the percentage of 
necrotic and/or apoptotic cells was increased after CLA addition directly into cultures was 
increased. In both in vitro studies 1.78.3.57 and 7.141 10"' M CLA were added into cell 
cultures. Although 1 ^ 10 " M CLA is considered physiological in human blood (Iverson et 
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al.. 1985). fetal calf serum (FCS). which was also used as an ingredient of the culture media 
is known to contain CLA (Park. 1996). It would increase the final concentration of CLA in 
the culture media. 
Spleen lymphocyte proliferation in mice fed 0.3% and 0.9% CLA (Wong et al., 1997) 
and 0.5% CLA (Miller et al.. 1994) was enhanced in phytohemagglutinin (PHA)-induced 
cultures. Neither .Miller et al. (1994) nor Wong et al. (1997) showed the number of counts per 
minute (cpm) in the non-stimulated wells obtained in their lymphocyte blastogenesis test, and 
therefore, it is not known if CLA increased the background proliferation and the mitogen-
induced proliferation or the mitogen-induced proliferation alone. T cell mitogens, such as 
PHA, concanavalin .A (ConA). and pokeweed mitogen (PKM) induce lymphocyte 
aggregation by binding to different carbohydrate residues in membrane glycoproteins. A 
greater mitogen-induced proliferation due to CLA addition suggests that CLA makes 
lymphocytes more capable of producing lL-2, which is consistent with the in vivo results of 
Wong et al. (1997) and Hayek et al. {1999). Both mechanisms, inhibition of eicosanoid 
production and PPAR-binding could e.xplain the increase of IL-2 production induced by 
CLA. The mechanism of inhibition of eicosanoid production by CLA has been discussed 
earlier. PPAR-CLA binding could influence IL-2 production because PPAR-gamma ligands 
modulate the activities of transcription factors including AP-1. STAT, and NF-kB (Ricote et 
al.. 1998) which are involved in the transcriptional regulation of most cytokine genes, 
including the IL-2 gene. The initiation of cytokine gene transcription requires several 
signaling pathways which activate different DNA-binding proteins simultaneously. The 
regulatory or enhancer region of the IL-2 gene, includes a 5" region of 300 base pairs in 
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which are located binding sites for several transcription factors, including AP-l, NF-icB. Oct-
1 and nuclear factor of activated T cells (NFAT) (Abbas et al.. 1997). 
Swine IL-2 shares a high degree of sequence conservation with other mammalian IL-
2 molecules (Bazan. 1992). IL-2 was shown to play an important role in fighting against viral 
infections (African swine fever virus, paramyxovirus, and po.xvirus) because it induced killer 
activity to porcine PBMCs (Scholl et al.. 1989; Steinmassl and Wolf. 1990). 
The assessment of the impact of a dietary immunomodulator on mitogen-induced 
responses provides information with regard to its effects on lymphocyte proliferation. 
However, the practical consequences of these findings sometimes are not clear. The 
assessment of the impact of CLA on antigen-induced responses would provide more subtle 
and valuable information with regard to potential applications of this nutritional enhancer of 
cellular immunity. 
CD8" T Cells 
Immunologists have used lymphocyte surface markers as a means to identify distinct 
lymphocyte subpopulations. These surface molecules are crucial for T cell tlinctions such as 
cell-cell interactions that are important for the development of a T cell response. In humans 
and mice membrane changes that occur after T cell activation are being elucidated at a 
molecular level. Kinetic studies about the binding affinity of the T cell receptor (TCR) for the 
peptide presented on the major histocompatibility complex (MHC). which in swine is called 
the swine leukocyte antigen complex (SLA), by the APC. gave very low values if compared 
with those of the antibodies (Matsui ei ai. 1991; Weber et al.. 1992). This explains, in part, 
that to overcome this low affinity recognition, accessory molecules are needed to achieve an 
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effective T cell response. Thus CD4 and CDS, along with other adhesion molecules, play an 
auxiliary role in antigen recognition by T cells (Weber et al.. 1992). 
Some of the surface molecules expressed by T cells (i.e.. CD2, CD4. CDS) have in 
common that their e.Ktracellular domain is similar in size to the ICR (approximately 50 KDa) 
(Dustin et al.. 1998). Furthermore. Dustin et al. (199S) and Monks et al. (199S) also 
suggested that cosegregation of (aP)2TCR/CD3. CD4 or CDS. CD2 (LFA-3 receptor), and 
CD2S occurs on T cells in response to activation signals. When these surface proteins 
interact respectively with their counterparts found on the APC membrane; (aP)2TCR/CD3 
and CDS or CD4 with MHC I or II respectively, LFA-3 {CD4S in mice and CD58 in humans) 
with CD2. and B7.1/B7.2 with CD28. a distance of 15 nm separates both cells (Dustin et al.. 
1998). These molecules, when co-segregated, constitute the central-SMAC (c-SMAC) 
(Monks et al.. 1998). Larger surface molecules, like CD45. and LFA-l (CD54), which bind 
to lCAM-1. are excluded from the contact area between the two cells. They span a gap of 
30-40 nm (Staunton et al.. 1990) and constitute the peripheral-SMAC (p-SMAC) (Monks et 
al.. 1998). Dustin et al. (1998) suggested that T cell activation induces the binding of CD2 
cytoplasmic domain and a CD2-associated protein (CD2.'\P). which promotes receptor 
patterning and cytoskeletal polarization. 
The better understanding of CDS"^ T cells is of crucial importance for this dissertation 
because I have shown for the first time that dietary CLA increases the percentage and total 
number of CDS in pigs. CDS" T cells must be understood as functionally distinct when 
compared, for instance, with CD4 T cells or B cells, but both CD4 and CDS cells will bear on 
their surfaces the membrane complexity described above. The CDS glycoprotein, although 
very important to phenotypically and functionally classify T cells, becomes, along with the 
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other molecular machinery ofT cell activation, a single element which plays an important 
role on the development of T cell responses. 
Most peripheral lymphocytes bearing the TCRaP develop from bone marrow stem 
cells but their progenitors migrate to the thymus where they mature (van Ewijk, 1991). 
Progression of thymocytes through distinct developmental stages is marked by induced or 
repressed expression of numerous regulatory components and cell surface markers such as 
CD4 and CDS (Ellemeier et al.. 1999). In the thymus, lymphocytes undergo positive 
selection and negative selection. Positive selection favors survival of lymphocytes capable of 
recognizing a foreign antigen in the context of self-MHC molecules (Naylor et al., 1997). 
Sometimes CDS cells are niisselected and express TCRs that do not recognize class I MHC. 
Pestano et al. (1999) described that there is a postthymic quality control mechanism that 
purges misselected CDS. The failure of mature CDS cells to simultaneously engage their 
TCR and CDS coreceptor triggers an activation process that begins with inhibition of CDS 
gene expression through remethylation and concludes with up-regulation of surface Fas and 
Fas ligand and apoptosis. Negative selection eliminates thymocytes whose TCRs recognize 
self peptide: self MHC complexes (Fink et al.. 197S). CD4-expressing cells express TCRs 
specific for MHC class II. whereas CDS'" T cells are MHC class I restricted. In humans. CD4 
are almost always helper cells that produce cytokines and CDS have a cytotoxic phenotype 
(granzyme and perforin producers). These cytotoxic T lymphocytes (CTLs) express the 
CDSaP molecule on their surface, which I will further characterize later. Most TCRyS-IEL 
and many TCRa(3-IEL. unlike thymus-derived T cells express a unique CDSaa homodimer 
instead of a CDSaP heterodimer and develop extrathymically in the intestinal mucosa 
(Kohyama et al.. 1999). Although today the concept that mucosal CDSaa can have 
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extrathymic development, whereas CDSaP cannot, should be updated. Levelt et al. (1999) 
found that CD8ap lEL development was independent of the presence of CDSaP T cells in 
the thymus, spleen, or lymph nodes. These findings suggest that CDSaP lELs were not 
derived from mature peripheral CDSaP cells. Mora et al. (1999) showed that NF-kB 
signaling is more important for the thymus dependent TCRapCDSap population than for 
other CDS lineages. Thus NF-ICB could be a regulator of the number, function, and normal 
balance of the peripheral CDS susbsets. Robey et al. (1996) reported that expression of an 
activated form of Notch I. a transmembrane receptor that controls cell fate decisions, in 
developing T cells of the mouse leads to both an increase in CDS and a decrease in CD4 
lineage T cells. Furthermore, notch activity favors the 76 T cell fate over the aP T cell fate 
(Washburn et al.. 1997). Levelt et al. (1999) showed that the affinity of the peptide presented 
on the MHC for the TCR was critical for the development of mucosal CDSaa and CDSaP T 
lymphocytes. They showed that high-affinity peptides induce maturation of CDSaa lELs. 
whereas low-affinity peptides stimulate the development of both CDSaP and CDSaa lELs. 
The requirements for survival of CDS T cells are important to understand the kinetics 
of that cell subset. Tanchot et al. (1997) showed that maintenance of murine CDS T cell 
memory requires TCR-MHC class I interactions, but memorv' CDS T cells have a lower 
functional activation threshold than naive CDS T cells that facilitates secondary responses. 
Cho et al. (1999) showed that murine memory CDS T cells differed from naive cells in 
requiring lL-15 for proliferation and in having a greater tendency to undergo apoptosis in 
vitro. On antigen stimulation in vivo, however, they proliferated more rapidly than naive 
cells. Another mechanism required for survival of correctly selected CDS has been explained 
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earlier aiid is related to the inhibition of a death signal through continued TCR-CD8 
coengagement of MHC molecules. 
CDS Molecule 
CDS is a cell surface 30-35 kDa dimeric glycoprotein that tlmctions as a coreceptor 
with the TCR (Janevvay. 1992). It binds to MHC class I and transmits signals to the nucleus 
through association with the cytoplasmic tyrosine kinase pSb''"'' (Gabert et al.. 1987; Dembic 
et al.. 1987: Barber et al.. 1989). Furthermore. Ick can also be found non-covalently 
associated with the cytoplasmic tail of CD4. On the other hand, a different tyrosine kinase 
called Fyn is associated with components of the TCR/CD3 comple.x. Both Fyn and Lck are 
implicated in proximal signal events that lead to TCR activation. CD8 can be expressed in 
two distinct molecular forms: either as a disulfide-linked aa homodimer or ap heterodimer 
(Norment et al.. 1988). Mice, in addition, can generate a distinct isoform of the a chain (a') 
that lacks the cytoplasmic tail by alternative splicing of the CD8a mRNA (Zamoyska et al.. 
1989). In humans the major form expressed in thymocytes and mature T cells is the aP 
heterodimer. but on a subset of NK cells and intestinal lELs only the CD8aa form is present 
(Sun et al.. 1997). Technologies, such as CLA. capable to increase the numbers of 
lymphocytes bearing CD8aa. could be used as a means to better understand the role of these 
subsets in humans, which numerically represent a very small percentage of the overall T cell 
population but functionally they might be very important. 
Human and chicken PBMCs have been shown to e.xpress both the aa homodimer and 
ap heterodimer. Since the aa homodimer has been found at a relatively lower density on the 
surface of human and chicken PBMC. it has been suggested that aP is more efficiently 
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expressed than aa (Moebius et al.. 1991; Breed et al.. 1996). In pigs this relationship is the 
same, but currently, there is no evidence suggesting that this variability is due to a 
differential efficiency in the expression of CD8aa or CD8aP 
The CDSp chain, unlike CD8a. is not directly involved in T cell signaling. The 
cytoplasmic tyrosine kinase p56''^'' is non-covalently. but tightly, associated with the alpha 
chain of CDS (Sun et al.. 1997) and it is involved in the early signal transduction events that 
occur upon T cell recognition of peptide-MHC complexes on APCs (Abbas et al.. 1997). In 
mice, the CXCP motif in the cytoplasmic tails of CDSa and CD4 binds to the cyteine 20 and 
cysteine 23 located in the unique motif of Lck (Shaw et al.. 1990). The C-terminus tyrosine 
(Y505 in Lck) renders the protein inactive upon phosphorylation because this allows the 
interaction with the SH2 domain on the same molecule. The protein folds over the non-
regulatory domain, hiding the catalytic domain. CD45 dephosphorylates Y505. which 
exposes the catalytic domain and the tyrosine in the catalytic domain can be phosphorylated. 
The Lck molecule is then active and can interact with its substrates: e.g.. ITAMs located in 
the CD3 molecule and components of the MAP/ERK kinase pathway (Cooper and Howell. 
1993). Wheeler et al. (1992) used a chimeric molecule containing the extracellular domains 
of CD8p linked to the transmembrane and cytoplasmic portions of CD8a to show that 
CD8ap had enhanced coreceptor function relative to CD8aa. .A possible explanation for that 
enhanced coreceptor function in CD8aP is because CD8 beta chain increases the sensitivity 
of the TCR by enhancing recruitment of the protein tyrosine-kinase Lck to the CD8 alpha 
chain (Levelt et al.. 1999). However, these differences in coreceptor ftinction between 
CD8aa and CD8aP are not because of higher affinity of CD8aP for MHC class I (Garcia et 
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al.. 1996). Lck is a protein tyrosine kinase (PTK) of the Src family e.xpressed mainly by T 
lymphocytes and thymocytes. Differences in function and cell distribution among members 
of Src-PTK are due to specific features found at the N-terminus or unique domain, which has 
myristoylation and palmitoylation signals. The rest of the molecular elements: SH3 and SH2 
domains, kinase domain and the C-terminus or regulatory domain are highly conserved 
(Bijlmakers and Marsh. 1999). The lck molecule contains two tyrosine residues at the 
catalytic and the C-terminus domains that regulate the PTK activity through a process of 
phosphorylation-dephosphorylation. 
The presence of CD8aa or CD8aP is also used to further define the T cell phenotype 
and to relate that phenotype to a function. In humans and mice, as almost all peripheral T 
cells bear the CD8ap heterodimer on their surtace. not much additional information is 
provided when measuring the type of CDS molecule expressed. However in swine, as 
opposed to what happens in humans or mice where CD8ap predominates, between 20 and 
40% of PBMC bear the CD8aa homodimer on their surface, whereas only between 7 to 13% 
of porcine PBMC are CD8ap (CTLs). Thus, pigs might be a good model to further 
functionally characterize the role of CD8aa subsets in humans. 
Cellular Immunology in Swine 
Distinctive Characteristics of the Porcine Immune System 
As I have mentioned earlier, evolutionary diversion between swine and humans or 
mice (Pastoret et al.. 1998) makes the porcine immune system different from the two species 
whose immune systems have been studied the most. There are some known differences with 
no apparent functional relevance for studies of nutritional immunomodulation for instance. 
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porcine lymph nodes are structurally inverted compared to other domestic species: lymphatic 
vessels enter into the lymph node through the hilus and lymph leaves through the cortex 
(Roth. 1999). Also. NK cells activity in most species, is associated with large granular 
lymphocytes because of bigger size and greater granularity than other lymphocyte subsets, 
whereas in pigs. NK activity is mediated by a small agranular lymphocyte subset that bears 
the CD2-T cell marker on its surface (Ferguson et al.. 1986: Duncan et al.. 1989). Most 
porcine NK cells also bear CD8aa on their surface. The complete phenotype of porcine NK 
cells is lg'CD2'CD3'CD4"CD8'''" (Zuckermann et al.. 1998). As it has been shown in other 
species, porcine NK cells serve as an early defense against certain intracellular infections. In 
humans. 5 to 10% of the peripheral blood lymphocytes are NK cells. They were first 
described as null cells displaying cytotoxicity against tumors without previous immunization 
to that tumor (Kuby. 1997). In swine. NK cell activty is high in peripheral blood and spleen, 
low levels in lymph nodes and no NK activity in the thymus (Pinto and Ferguson. 1988). 
However, there are other differences, which might be of crucial importance to better 
understand porcine immune responses. Two important differences of functional importance 
are the large number of cells bearing TCRyS in swine (Binns et al.. 1992: Binns. 1994: Binns 
et al.. 1994). which is also important in other ungulates (Roth. 1999). and the presence of 
mature extrathymic CD4CD8 double positive T cells (Pescovitz et al.. 1994: Zuckerman and 
Husmann. 1996: Summertleld et al.. 1996). 
76 T cells are capable of recognizing intact antigen molecules, similar to the way 
antibodies recognize antigen (Kaufmann. 1996). In humans and mice. 90% of peripheral T 
cells express TCRap on their surface and only 10% TCRy5. whereas the latter represent a 
major T cell population of the epithelia in skin and mucosae (Kaufmann. 1996). In swine. 
TCRyS cells represent a major peripheral T cell subpopulation. Porcine TCRy6 cells were 
initially studied by differential identification (PBMC minus CDS and CD4 and B cells). 
When swine immunologists did not have a monoclonal antibody (mAb) anti-TCRyS there 
was a population of lymphocytes defined as null cell population. The reason being that these 
lymphocytes did not express CD4. CDS or B cell markers (IgM) on their membrane. 
However, after a mAb specific for a conserved region of TCRy6 {PGBL22A) was developed, 
it was concluded that the majority of porcine null cell population was primarily made up of 
TCRy6 cells (Davis et al.. 1998). PGBL22A. the only mAb that detects all CD2^ and CD2" y8 
T cells, might recognize a highly conserved determinant on one of the three described 
porcine y chains (Thome et al.. 1993. 1994) or on the 6 chain (Davis et al.. 1998). 
y6 T cells can express the TCRy6 alone or together with CDSaa. However. Davis et 
al. (1998) include in their definition of null cell population those TCRy6 cells also expressing 
CD8aa on their surface. 1 believe that this is not an accurate definition of the null cell 
population. The reason is that TCRy6CD8aa cells would be included in the CDS'"^^ sub-
population when measuring CD4 versus CDS therefore, they were not indeed a part of the 
population of cells not bearing CD4. CDS or B cell markers on their surface, which is the 
definition of null cell population. Licence et al. (1995) described that y5 T cells were mainly 
thymus-dependent. but a small population of thymus-independent y6 T cells was also 
described and followed for 2 years after thymectomy. 
An additional degree of complexity is added to the y6 T cell population when 
considering surface CD2 expression. The CD2^ subpopulation is comprised of subsets that 
are negative or positive for CDSaa. Approximately 40 to 50% of the TCRy5CD2^ T cells 
coexpress CDS. whereas CD4 positive 76 T cells have not been observed (Davis et al., 1998). 
The TCRy6CD2" T cell subset is low in concentration in peripheral blood and high in the 
spleen, suggesting that this population differs from the CD2' subset in propensity for homing 
and regionalization in specific tissues and lymphoid organs (Saalmuller et al., 1990). The 
TCRy5CD2" T cell subset is high in concentration in peripheral blood and low in 
concentration in lymphoid organs (Saalmuller et al.. 1990). TCRy5CD2' T cells have a high 
rate of turnover with minimal residency time in various lymphoid organs and tissues (Binns. 
1994). In mice y6 T cells participate in antimicrobial immunity, but they perform primarily 
compensatory functions in the absence of aP T cells (Kaufmann. 1996). Accordingly, murine 
y5 T cells differ from ap T cells in their localization and kinetics rather than in their effector 
functions. It would be interesting to investigate whether what occurs in porcine y5 T cell 
subsets with regard to CD2 expression is actually a matter of differential localization or when 
TCRy6CD2" T cells reach a lymphoid organ initiate surface CD2 expression and decrease 
recirculation rate. 
The larger number of CD8aa recirculating lymphocytes in swine relative to mice or 
humans is an important distinctive characteristic of porcine cellular immunity. This is 
because several cellular subsets bear CD8aa on their surface. 1 am going to discuss the 
characteristics of these subsets later. Now I will discuss a peripheral T cell subset which is 
typical of swine, but is not found in other species. Other species express CD4 CDS DP T 
cells only in the thymus and they are immature lymphocytes. In pigs it was initially thought 
that CD4CDS DP were premature thymic emigrants, but this hypothesis was discounted 
when the absence of CDl surface expression (CDl is expressed in thymic immature T cells) 
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was demonstrated on peripheral CD4CD8 DP T cells (Pescovitz et al.. 1990). Thus, 
extrathymic coexpression of CD4 together with CDS at low density (CD8aa) in swine 
mature lymphocytes has been shown to identify lymphocytes which functionally can be 
defined as T helper cells, and as indicated by the fact that CD4CD8 DP T cells increase with 
age. they are involved in recall-type responses (Pescovitz et al.. 1994; Zuckerman and 
Husmann. 1996; Summertield et al.. 1996). Therefore, the concept of divergence in 
developmental programming, used by human and mice immunologists to explain that genes 
involved in the killing of target cells are activated in CD8ap T cells (CTLs). whereas various 
cytokine genes are activated in effector CD4 T ceils (Von Boehmer et al.. 1989). cannot be 
strictly applied to swine immunology. In the future, it will be crucial for the development of 
swine immunology to elucidate what advantage is provided to the porcine immune response 
through the expression of CD8aa on CD4 T cells. Are these CD4CD8 DP SLA complex 
class 1 and SLA complex class II restricted compared to CD4 which are only SLA class II 
complex restricted? At the present time we do not have an answer to that question. However, 
it is known that CD4CD8DP T cells express the TCRaP and not TCRyS on their surface, and 
might have developed extrathymically (Licence et al.. 1995). 
Finally, another important immunological difference between swine and other animal 
species is that the diversity of the variable region of the 6 chain (Ye;) of the TCRyS is the 
greatest in pigs among all animal TCRs studied (Yang et al.. 1995). In humans and mice 
because numbers of the variable (V). diversity (D) and joining (J) gene segments for TCRy5 
are low. rearrangements alone are insufficient for creating an equally large diversity as they 
do in Ig and TCRap. However, a similarly large repertoire is achieved through the 
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generation of immense junctional diversity (Kaufman. 1996). That slightly decreased 
diversity described in humans and mice due to low numbers of TCRy6 V. D and J genes, 
could negatively influence the efficacy of an immune response in which TCRyS cells play a 
fundamental role. Maybe that fundamental role would only be compensatory functions in the 
absence of ap T cells, such as in mice, or perhaps in swine y6 T cells perform a more 
important function. However if either y6 T cells are functionally more or less important in 
swine, the enormous diversity of V.s could partly overcome the genetic limitations that in 
humans and mice have been imposed to the TCRy6. 
Immune Cell Phenotype and Function in Swine 
CDS Cell Population 
The CDS lymphocyte population is numerically and functionally the most important 
lymphocyte subset in pigs. Both phenotypically and functionally. CDS lymphocytes 
constitute a non-homogeneous population made up of several subsets. Porcine CDS 
lymphocytes are also of particular importance to this dissertation because I have shown for 
the first time that the percentage and total number of porcine CDS cells is increased in 
response to dietary CLA. Phenotypic differences are potentially correlated with distinct CDS 
lymphocyte subsets. There are basically five distinct lymphocyte subsets bearing the CDS 
molecule on their surface in swine, and four of them bear the CDSaa homodimer, whereas 
only one subset bears the CDSaP heterodimer (TCRapCDSaP). A subset of CDS^ cells in 
swine preferentially e.xpress SLA complex class II on their surface (Lunney. 19S7). It is not 
known why some porcine CDS" cells express SLA complex class II on their surface, whereas 
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CD8^ cells in other species do not express MHC class 11. Another unique feature of porcine 
SLA complex is that it maps across the centromere of chromosome 7 (Smith et al.. 1995). 
At the present time, porcine CDS genes have not been cloned and sequenced, 
therefore, to relate a particular CDS phenotype to a cell subset, some inferences have to be 
made. The development of a mAb specific for either an epitope of the p chain or for a new 
epitope formed by the combination of the a and p porcine CDS chains (PG164A) allowed 
swine immunologists to infer that CDS'^'='^ lymphocytes represented the TCRapCDSaP 
(CTL) T cell subset (Yang and Parkhouse. 1997; Zuckermann et a!.. 1998). Porcine 
TCRapCDSap cells, such as NK cells, have a cytotoxic function. TCRapCDSap play an 
important role in the adaptative. and NK in innate, cell-mediated immune responses to 
viruses or other intracellular type pathogens. CTL specific activity for hog cholera virus and 
African swine fever has been demonstrated in pigs recovered from infection (Martins et al.. 
1993: Pauly et al.. 1995). 
The mechanism of action of TCRapCDSap has been postulated in mice and humans. 
There are not mechanistic studies in the pig with regard to how cytotoxicity occurs. It is 
assumed, although it has not been demonstrated, that porcine CTLs have a mechanism of 
action similar to human or murine CTLs. TCRapCDSap can be functionally divided into 
two subsets: Pre-CTLs and CTLs. Pre-CTLs are T cells that are committed to the CTL 
lineage, have undergone thymic maturation, and are already specific for a particular foreign 
antigen (Abbas et al.. 1997). Pre-CTLs will differentiate into CTLs after two signals: specific 
antigen recognition of antigen on a target cell and co-stimulation which may be provided 
either by co-stimulators expressed on professional APCs or by cytokines such as IL-2 and 
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interteron-y (INF-y) produced by helper cells (Kagi et aL. 1996). Differentiation from pre-
CTLs to CTLs involves, among other effects such as INF-y production or surface Fas ligand 
expression, the activation of genes coding for the membrane pore-forming protein called 
perforin and the enzymes with serine esterase activity called granzymes (Abbas et al.. 1997). 
When a TCRap on the CTL surface recognizes a peptide/ MHC class I complex on a 
target cell, a tight junction formation occurs in a way similar to the formation of SMACs 
described earlier. Also, similarly to what occurred in SMAC organization, there is a 
reorientation of the cytoskeleton. but in this case the objective is to focus the release of 
effector molecules (granzme and perforin) at the site of contact with the target cell ( Janeway 
et al.. 1999). Perforin will make a pore in the membrane of the target cell and granzyme will 
go through that pore to activate the caspase cascade, which will result in induction of 
apoptosis (Kagi et al.. 1994). In my research. I have measured granzyme activity as an 
indicator of cytotoxicity, thus I have assumed that the mechanism of cytotoxicity in mice, 
humans and swine is similar. There are two additional mechanisms of induction of apoptosis 
not involving the caspase cascade. 
NK cells are cytotoxic lymphoid cells capable of killing a variety of nucleated cells 
without previous antigenic stimulation (Roth. 1999). Thus. NK cells are a part the innate cell-
mediated immunity, whereas CTLs are a part of the adaptative cell-mediated immunity. The 
involvement of CTLs in the cellular response to African swine fever described above has its 
NK cell homonym: Evans et al. (1993) showed that swine NK cells are capable of lysing 
cells infected with transmissible gastroenteritis virus and pseudorabies virus. Enhancement of 
cytotoxicity as a result of cytokine co-stimulation, as mentioned when discussing the 
differentiation from pre-CTLs to CTLs, also occurs when NK cells ditferentiate into 
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lymphokine-activated killer (LAK) cells (Cho et al.. 19%). Swine NK cells respond to an 
interferon inducer (poly I:C). lL-2. human interferon-a (IFN-a). and human IL-la with 
enhanced NK activity (Lesnick et al.. 1988; Knoblock et al.. 1992: Evans et al., 1993). In 
contrast to what occurrs in CTL function which is a cytokine- or/and a surface-APCs-co-
stimulator-driven phenomenon, in the case of NK cells, it would be only a cytokine-driven 
co-stimulation. The disadvantage of NK cells compared to CTLs is that they are not antigen-
specific cells. The advantage is that NK cells are MHC-nonrestricted. therefore, they can kill 
a target cell, even when there is a downregulation of MHC class [ expression, which may 
occur in certain viral infections. 
Earlier, i have described the structural differences (size and granularity) between 
porcine NK and other species NK cells along with the fact of being a part of the CDS 
population of cells, whereas human NK cells, when discovered, were considered a part of the 
null cell population (Kuby. 1997). therefore some human NK cells do not e.xpress CD8aa on 
their surface. Surface expression of CD8aa alone does not indicate that a particular porcine 
cell is a NK cell. The reason being that CD8aa molecules will be expressed on the surface of 
some of the TCRy6 cells, also on CD4CD8 DP cells and some CDS SP T cells. Therefore, to 
relate a particular phenotype to a cell subset and to a function, additional cell surface markers 
should be considered. G7 and PNK-E are two mAb that enhance porcine NK cell activity by 
binding to cytolytic trigger molecules which exist as a molecular complex on porcine NK 
cells (Johnson et al.. 1991). The PNK-E molecule seems to be distinct from CD2 and CD 16 
(Johnson et al.. 1991). 1 have shown that almost all porcine G7 and/or PNK-E positive cells 
also bear CDSaa molecules on their surface in vivo. 
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Recently, the G7 molecule has been cloned and identified as porcine FcyRIHAa chain 
(Hailoran et al.. 1994). This molecule would most likely be involved in antibody-dependent 
cellular cytoto.xicity (ADCC). ADCC is an immunological mechanism that serves NK cells 
to overcome the problem, which is intrinsic to their non-specific nature, of how to be directed 
against specific target cells. NK cells express on their membrane receptors capable of binding 
the Fc region of IgG (Fc/R). NK cells along with macrophages, monocytes, neutrophils, and 
eosinophils use ADCC as a means to enhance their specificity (Kuby. 1997). However, 
among all these cellular types, only NK cells will express both CD8aa and FcYRIllAa 
(CD 16). The IgG bound to the FcyR will have antigen-specificity in the Fab region, which if 
it is specific for a surface antigen presented on a target cell a cytotoxic-type of response will 
occur. The molecular mechanism of NK cell cytotoxicity can be the same described above 
for CTL cytotoxicity (granzyme and perforin). 
There is not a definitive direct proof of the existence of porcine TCRapCDSaa T 
cells. The reason being that, in swine, a mAb for the TCRaP has not been developed. Based 
on the type of CDS dimer expressed on the cell surface. TCRy6"CD3 *" populations, which 
were inferred to be TCRaP". can be further divided into two cell subsets cells expressing 
CD8'"='' (TCRapCDSaP) and cells expressing CDS'"^^. The CDS'"" population will be a 
CDSaa dimer-e.xpressing cell subset, including TCRapCD4CD8aaDP. NK (CD3" 
G7^CD8aa). and potentially TCRapCDSaa cells. Dot plots showing CD4CD8aaDP T 
cells and NK cells as separate populations are available from several publications 
(Zuckerman et al.. 1996; Zuckermann et al.. 1998; Johnson et al.. 1991). However, because 
of the lack of available mAb anti-porcine TCRap, at the present time, there is no direct flow 
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cytometric evidence showing the porcine TCRapCDSaa T cells subset as a separate TCRyS" 
CD3^ T cell subset. Research by Yang and Parkhouse (1996) represent the only published 
proof, yet indirect, of TCRapCDSaa T cells existence in pigs. After developing a mAb anti-
porcine CD3 epsilon chain (Yang et al.. 1996), they conducted a three-color fiow cytometric 
analysis assaying for CD4. CDS and CD3 or TCRy6. The percentage of porcine 
TCRapCDSaa T cells in PBMCs was calculated by substracting the percentage of 
TCRy6CDSaa in PBMCs from the percentage of CD3CD8aa in PBMCs. From these 
calculations, it was reported that only 3.7 ± 1.4 % of PBMC were TCRapCDSaa T cells. 
Two important porcine CDS subsets (TCRapCD4CDSaa DP. and TCRySCDSaa) 
along with TCRyo cells have been discussed together with other distinctive characteristics of 
the porcine immune system, therefore, they will not be discussed again here. Because 
activated effector CD4 cells are involved in cytokine production, this subset will be discussed 
along with some porcine cytokines important for CLA-induced immunomodulation. 
B Cell Population 
In swine, surface IgM e.xpression is used as a B cell marker. Porcine B cells, such as 
B cells of other species, differentiate into plasma cells, the effector cells of the humoral 
immune system, capable of secreting antibodies. The first antibody will be IgM and after 
that, through isotype switching IgG. IgA and IgE will be produced. Isotype switching is 
regulated through interleukins produced by Th cells (CD4). Th cells located in lymph nodes 
and spleen favor switch to IgG. whereas Th located in mucosae (e.g. GALT and BALT) 
induce B cells to switch to IgA/ IgE (Roth. 1999). Sugano et al. (199S) described that, in 
mice, dietary CLA induces an increase in IgA. IgG and IgM. and a decrease in IgE in 
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lymphocytes from both spleen and MLN. In pigs it has not been reported that CLA 
influences humoral immunity. 
Cytokines 
CLA influences cytokine production through the inhibition of eicosanoid production. 
Also, if CLA is a PPAR ligand. it might be involved in the transcriptional inhibition of pro­
inflammatory cytokine production. There are two distinct cytokine-driven events that could 
be regulated by CLA: cell proliferation and differentiation, and inflammatory responses. 
Firstly, the effects of CLA on cell proliferation and differentiation involve an increase in lL-2 
production, which 1 have discussed earlier. Secondly, the putative decrease in inflammation 
caused by dietary CL.\ could be explained through either a decrease in pro-inflammatory 
cytokine production (PPAR-y ligands decrease pro-inflammatory cytokine production), or by 
blocking the effects of pro-inflammatory cytokines (CLA blocks the effects of TNF-a on 
protein degradation (Park. 1996)) or both. 
Inflammatorv' cytokine (lL-1. IL-6. lL-8. TNF-a. TNF-(3) expression is induced 
principally by cell wall products of gram-negative bacteria and activators of the transcription 
factor NF-kB (Pastoret et al.. 1998). Inflammatory cytokines are produced by macrophages 
and/or T cells, and induce inflammatory responses. 
The revolutionary concept of Thl-Th2 paradigm that Mosmann et al. (1986) proposed 
was based on mice studies. They proposed that CD4 T cells were divided into two subsets 
based on the type of cytokines that they produced and. therefore, the subsequent irmnune 
response derived from that distinct cytokine production. Mosmann et al. (1986) indicated that 
a Thl-type response will produce IFN-y, whereas a Th2-type response will induce IL-4, IL-5 
and IL-6 production. There is no definitive evidence of the existence of the paradigm in non-
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murine models, therefore, if the concept is to be applied in swine. T helper responses should 
be defined as Thl-like and Th2-like responses. 
Swine Dysentery 
Swine dysenter\' (SD) is an inflammatory, mucohemorrhagic diarrheal disease that 
affects pigs during the growing-finishing period caused by Brachyspini hyodysenteriae 
(Harris et al.. 1999). It has been estimated to cause about 180 million dollars of financial loss 
annually (Joens. 1990). These losses can be attributed to three main reasons: mortality, 
decreased growth, and the cost of antibiotic therapy. Antimicrobials have been used at sub-
therapeutical levels in the diet to prevent SD along with other bacterial diseases. However, 
restrictions to the use of antimicrobials were imposed in the European Union and probably, 
in the future, similar restrictions will be adopted by the United Stales. Therefore, 
antimicrobial-free prevention of infectious inflammatory diseases such as SD should be 
approached differently. A possible therapeutical approach is to induce a type of immune 
response in the animal that is prone to decrease inflammation which would be favorable to 
the prevention or to the resolution of the disease. That antimicrobial-free prevention strategy 
could be achieved by using effective vaccination protocols and/or natural dietary 
immunomodulators capable of inducing the desired type of immune response. 
Based on the similar effects elicited by dietary CLA (Bassaganya-Riera, et al.. 1998; 
Bassaganya-Riera et al.. 1999) and a SD vaccine (Waters et al.. 1999: Waters et al., 2000) in 
increasing the percentage of porcine peripheral CDS" cells, an experiment with the purpose 
to measure the effects of CLA in the efficacy of a SD vaccine was included in this 
dissertation. Waters et al.. (2000) showed that the increase in percentages of CDSaa" cells, 
possibly driven by cytokines produced by CD4'^ cells, corresponded with the onset of 
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resolution of SD infection in pigs. Therefore, immunomodulatory strategies capable of 
increasing CD8aa' cells might contribute to prevent SD. 
Although the mechanism by which CLA or the SD vaccine induce the increase in 
porcine peripheral blood lymphocytes phenotype is not known, a possibility is that both, in 
different ways, are modulating cytokine e.xpression. The proposed role of CLA as a PPAR 
ligand. along with interesting discoveries suggesting novel therapies for human inflammatory 
bowel disease (IBD). could open the door to new applications for dietary CLA. 
Because many enteric inflammatory diseases, such as SD. display similarities in their 
pathogenesis. SD is a good model to study the impact of other enteric inflammatory diseases 
in gastrointestinal health and function. For instance, clinically. SD resembles IBD. a chronic 
debilitating disease that affects millions of people worldwide. Recent research on IBD 
conducted in cytokine-knockout mice models (Elson et al.. 1995) indicates that this 
intlammatorv- disease is the result of loosing the balance that maintains the intestinal mucosa 
in a quiescent state of inflammation. Intestinal epithelium is the interface between a highly 
antigenic luminal environment and the mucosal immune system (Su et al.. 1999). 
Interestingly, enterocytes are not simple passive players in the regulation of the interactions 
between the intestinal lumen and the mucosa. They have been shown to express various 
cytokine receptors (Reinecker et al.. 1995). and cytokines and complement factors (Andoh et 
al., 1993; Williams. 1998) that could potentially influence the maintenance of the quiescent 
state of inflammation. 
Su et al. (1999) proposed a novel therapy for IBD-induced colitis that consists of the 
utilization of PPAR-y ligands to inhibit the epithelial inflammatory response. They showed 
that PPAR-y not only regulates growth and differentiation but also regulates itrmiune 
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responsiveness by interfering with NF-kB activation and subsequently with the ability of 
colonocytes to express immunomodulatory cytokines. They mentioned a series of PPAR-y 
ligands that could be used as therapeutic agents. Amongst these PPAR-y ligands they used a 
new class of oral antidiabetic agents called thiazolidinediones (TZDs) to test their hypothesis. 
The result was that TZDs markedly reduced colonic inflammation in a mouse model of IBD. 
.•\n additional advantage of using PPAR-y ligands in prevention and therapy of intestinal 
inflammatory disease would be derived from inhibiting the activation of NF-kB induced by 
bacterial lipoproteins (BLPs) which play an important role in the initiation of inflammation 
(Aliprantis et al.. l')99). 
•As 1 am going to further elaborate later, currently, there is enough information in the 
literature to infer that CLA is a PPAR-y ligand. Therefore, based on the work conducted by 
Su et al. (1999) it is proposed that dietary CLA could be utilized as a novel therapeutical 
and/or preventive approach for enteric inflammatory diseases such us SD and IBD. 
.Approach tu the Moicculur Basis of Dietary Fatty Acid-induced Immunomodulation 
As mentioned earlier, the third phase of fatty acid research is the phase with the 
strongest molecular basis. The origin of that molecular basis is attributed to a group of 
nuclear receptors, which were initially lacking known ligands (Kastner et al., 1995), called 
orphan receptors. When nature spends energy in creating something and evolution does not 
eliminate that process, it is because it must have a function. It is likely that orphan receptors 
not only interact with hormones, but they might represent the missing link between nutrients 
and genes. 
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Nuclear receptors are ligand-inducible transcriptional regulators involved in 
embryonic development, cell differentiation, homeostasis, and are implicated in cancer, 
diabetes or hormone resistance syndromes (Gronemeyer and Laudet. 1997). Dietary 
components are often competent to interact with nuclear receptors and to activate their gene 
regulatory networks (Gustafsson et al.. 1998). PUFAs (e.g.. linoleic. linolenic and AA), 
monounsaturated fatty acids (e.g.. oleic and elaidic). saturated fatty acids (e.g.. palmitic and 
stearic). PGs and LTs interact with the orphan receptor pero.xisome proliferator-activated 
receptor (PP.AR) (Gottlicher et al.. 1992: Gustafsson et al.. 1998). PPARs belong to the 
superfamily of hormone receptors (e.g.. steriod hormones, retinoic acid, vitamin D. and 
thyroid hormones represent other compounds eliciting their actions on other members of that 
superfamily) (Wolf. 1998). All members of this family have in common; a DNA-binding 
domain, a gene-acti\ ating domain and a ligand-binding domain. When the ligand binds to the 
receptor, the receptor can interact with DNA and thereby activate or deactivate specific genes 
(Wolf. 1998). Many genes harbor a pero.xisome-proliferator-receptor element (PPRE) 
sequence. They are two sites consisting of the nucleotide sequence AGGTCA separated by a 
single base pair which bind a PPAR/RXR dimer (RXR is the retinoid X receptor) (Wolf. 
1998: Desvergne et al.. 1995: Semba. 1998). This information provided at the molecular 
level indicates that a potential for interaction between vitamin A and CLA e.xists. 
Houseknecht et al. (1998) showed that dietary CLA is associated with elevated levels 
of a number of genes that are responsive, in part, to PPAR-y. Activation of PPAR-y by 
PPAR-y ligands has been linked to decreased circulating glucose levels and improved insulin 
action in animals and humans (Saltiel et al.. 1996). Furthermore, PPAR-yl protein expression 
in WBC undergoes a dynamic change with endotoxin challenge (Leininger et al., 1999), 
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which indicates that PPAR-yl may play an important role in the development of an immune 
response to lipopolysaccharide (LPS). 
Also. CLA has structural and physiological characteristics similar to peroxisome 
proliferators (Su et al.. 1999). Peroxisome proliferators are compounds that cause an 
increase in the number and/or the size of liver peroxisomes. Peroxisomes are cytoplasmic 
organelles surrounded by a lipid membrane which contain a group of enzymes active in lipid 
catabolism (Desvergne et al.. 1995). PPARs are ligand-activated transcription factors that 
affect gene expression. Three [PPAR-a. PPAR-p (also called PP.AR-6. FAAR or NUCl), 
and PPAR-yI subtypes of PPARs have been described (Grindflek et al., 1998). Because 
orphan receptors sometimes cannot be described by their function the existence of several 
genes with the same name is an important problem. Recently, with the purpose to solve that 
problem, a unified nomenclature system for the nuclear receptor superfamily was developed. 
Based on that system NRICI. NR1C2 and NRIC3 represent PPAR-a. PPAR-p and PPAR-y, 
respectively. CLA is able to activate PPARs while not being a peroxisome proliferator 
(Moya-Camarena et al.. 1999). PPAR-y is e.xpressed at high levels on colonic cells and 
regulates growth and differentiation (Su et al.. 1999). inhibits production of monocyte-
derived intlammator>' cytokines (Jiang et al.. 1998). and modulates the activities of 
transcription factors including AP-1. STAT, and NF-kB (Ricote et al.. 1998). These 
transcription activators are involved in the transcriptional regulation of inflammatory 
cytokine expression (e.g.. IL-l. IL-6. and TNF-a) which can induce a decrease in growth and 
feed intake. Tlierefore. compounds capable of decreasing the expression of inflammatory 
cytokines could provide health benefits in diseases where inflammatory cytokine production 
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contributes to the pathogenicity of the disease. 
PPAR-y elicits other important biological effects. Rosen et ai. (1999) described that 
PPAR-y is required for differentiation of adipose tissue in vitro and in vivo. PPAR-y is 
abundantly e.xpressed in both white and brown adipose tissue and is induced before 
activation of most adipose-specific genes (Kliewer et al., 1994). Mutations of PPAR-y that 
destroy receptor function have been found in sporadic colon cancer (Mansen et al., 1996; 
Brockman et al.. 1998; Elstner et al.. 1998; Mueller et al.. 1998; Sarraf et al.. 1998. 1999; 
Tonotoz et al.. 1998). PPAR-y is also required for placental and cardiac development. Its 
deficiency interferes with terminal differentiation of the trophoblast and placental 
vascularization, leading to severe myocardial thining and death (Barak et al.. 1999). 
The porcine PPAR-y gene encodes a 1.8 kb mRNA transcript and shares 99. 96 and 
97% amino acid sequence identity to the human, mouse and cow PPAR-y molecule 
(Houseknecht et al.. 1998). respectively. In swine, two isoforms derived from alternate 
promoter usage and differenual splicing of PPAR-y. yl (spleen) and y2 (adipose tissue), have 
been characterized (Grindtlek et al.. 1998). Spurlock et al. (1999) reported that PPAR-y2 
mRNA was increased 4-fold in pigs by soybean oil compared to a non-added fat diet. PPAR-
yl isoform is e.xpressed in lymphocytes. Thus, dietary CLA. as well as other dietary fatty 
acids, could modulate the transcription of cytokine mRNA. which inhibits inflammatory 
responses and enhances lymphocyte proliferation. Both linoleic acid and CLA should be able 
to bind PPARs (Gottlicher et al.. 1992; Houseknecht et al. 1998; Gustafsson et al.. 1998). 
However, the effects derived from linoleic acid binding are distinct from those derived firom 
CLA-binding. When CLA is the PPAR ligand there is no peroxisome proliferation, whereas 
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it occurs when other fatty acids bind to PPAR (Houseknecht et al. 1998). The environment in 
which ligation and activation occurs should be an important element in defining the final 
outcome. PPAR binding in a context of high eicosanoid levels (high dietary Hnoleic acid) 
might have a different outcome than binding in a CLA-derived low eicosanoid environment. 
.A.lthough not included as an objective for this dissertation, the study of CLA at the 
molecular level should be included as a recommendation for any future research on CLA and 
immune function. A possible application of that type of research would be to identify the 
anti-inflammatory properties of CLA. After proving that CLA is an anti-inflammatory 
compound on the whole animal, claims regarding the use of CLA as a natural product that 
enhances gastrointestinal health and function could be made. 
Possible Interaction Between Vitamin A and CLA 
To look at the interaction between CLA and vitamin A is not the purpose of this dissertation. 
However, there is enough molecular basis to suggest that interactions between the 
compounds may occur. Both vitamin A (Table 3) and CLA elicit important 
immunomodulatorv- effects, which in the case of vitamin .A have already been reported in 
several NRC publications. However most of these NRC reviews focussed exclusively in 
general aspects of the maintenance of epithelial integrity and not on immune cell phenotype 
and function or immune response. 
In 1915. McCollum and Davis described that fat soluble A (vitamin A was a 
component of fat-soluble A), had growth promoting activity. Drummond (1920) suggested 
the designation as vitamin A. Green and Mellanby (1928) described vitamin A as the "anti-
infective" vitamin. Since that phenomena was described, science has provided additional 
information regarding sources of vitamin A, absorption, metabolism, toxicity, existence of 
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Table 3. Immune response functions that could be regulated by retinoids 
Element References 
Natural killer cell function Zhao etal., 1994 
T cell function Rahman etal.. 1997 
IL-2 production Colizzi etal.. 1985 
Monocyte/ macrophage function Szaboetal.. 1994 
TGF-P production Fisher et al.. 1992: Szabo et al.. 1994 
Phospholipase .A.: production Hope et al.. 1990 
Cytotoxic T lymphocyte function Malkovsky et al.. 1983: Sijtsma et al.. 1990 
Adapted from Semba. 1998. 
intracellular binding proteins, and its pleiotropic effects of vitamin A derivatives (on vision, 
reproduction, embryonic development, grovvlh, keratinization. enzyme activity and immune 
function), which are transduced by two families of nuclear receptors. With the exception of 
vision, where retinal and retinol are the derivatives used, retinoic acid has been shown to be 
the active vitamin .A derivative (Ghyselinck et al.. 1999). 
Two families of nuclear receptors, all-trans retinoic acid receptors (RARs) and 9-cis 
retinoic acid receptors (RXRs) have been identified, which consist of three isotypes (a. P and 
y) that control gene e.xpression by retinoid signals (Chambon. 1996). RARs and RXRs form 
RAR/RXR heterodimers and RXR/RXR homodimers and bind to retinoic acid response 
elements (RAREs) and retinoid X receptor response elements (RXRE) of target genes, 
respectively. As indicated earlier, a consensus sequence 5"-AGGTCA-3' is the core 
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recognition element for the entire family of nearly 150 non-steroid nuclear receptors to which 
RXR. PPAR and RAR belong (Mangelsdorf and Evans. 1995). Interestingly, all RXR 
heterodimers preferentially bind response elements composed of two AGGTCA sites 
arranged in a direct repeat configuration with characteristic inter-half-site spacings of 1-5 bp 
called DR1-DR5 (Mangelsdorf and Evans. 1995). RXR/RXR may inhibit the formation of 
heterodimers (Pfahl et al.. 1996). RXRs may also form heterodimers with the thyroid 
hormone receptor (TR). vitamin D3 receptor (VDR). nerve growth factor induced-B (NGFI-
B) receptor. PP.ARs and other orphan receptors (Semba. 1998). 
Table 4. PPAR and retinoid receptors 
Item PPAR Retinoid receptors 
Nuclear receptor PPAR RAR/RXR 
Receptor subtypes alpha, beta and gamma alpha, beta and gamma 
Dimers formed RXR/PPAR RAR/RXR. RXR/RXR 
Region in the DNA PPRE RARE and RXRE 
Ligand-binding region Fatty acids. PGs. LTs all-trans/ 9-cis retinoic 
Adapted from Semba. 1998 and Wolf 1998. 
The core sequence of the DNA-binding domain (DBD) is highly conserved in the 
nuclear receptor superfamily. This sequence is comprised of two zinc-nucleated modules and 
two a-helices that fold into a single globular domain (Rastinejad et al.. 2000). Gronemeyer 
and Moras (1995) raised a fundamental question critical for the molecular and functional 
understanding of nuclear receptors: Considering that DBD and its core binding sequence are 
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highly conserved among different nuclear receptors, how are distinct signalling pathways 
created in this transcription factor superfamily? 
PPAR-RXR heterodimers serve as the core of signaling units (Barak et al., 1999). 
Mukherjee et al. (1997) showed that RXR-specific ligands were capable of promoting typical 
PPAR-y activities, such as macrophage differentiation, in cultured cells alone and in synergy 
with PPAR-y ligands. Knock-out mice studies showed that RXR deficiency phenotypes arise 
primarily from a failure to execute PPAR-y functions (Barak et al.. 1999). Elstner et al. 
(1998) showed that ligands for peroxisome proliferator-activated receptor gamma and 
retinoic acid receptor inhibit growth and induce apoptosis of human breast cancer cells in 
vitro and in mice. RARs and RXR may interact with multiple transcriptional mediators 
and/or corepressors. adding an enormous level of complexity to regulation of retinoic acid 
responses (Semba. 1998). This complexity would become greater when retinoic acid 
responses were investigated with the addition of other variables such as PPARs (dietary fatty 
acids) or other orphan receptors. 
Thus, the molecular interaction between CLA and vitamin A could provide a stronger 
dietary immunomodulation than when CLA is fed alone. Vitamin A deficiency impairs CDS 
cytotoxic T lymphocyte activity in chickens infected with Newcastle virus (Sijtsma et al., 
1990). CLA increases the percentage of CDS T cells in pigs (Bassaganya-Riera et al.. 1998; 
Bassaganya-Riera et al.. 1999). The fact that both CLA and vitamin A have an impact on 
CDS T cell subsets indicates that this molecular relationship might have biological synergy in 
the v/hole animal. 
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CHAPTER 2. EFFECTS OF DIETARY CONJUGATED LINOLEIC ACID (CLA) IN 
NURSERY PIGS OF DIRTY AND CLEAN ENVIRONMENTS ON GROWTH, 
EMPTY BODY COMPOSITION AND IMMUNE COMPETENCE 
A paper to be submitted to the Journal of Animal Science 
Josep Bassaganya-Riera. Raquel Hontecillas-Magarzo. Kristjan Bregendahl. 
Michael J. Wannemuehler. and Dean R. Zimmerman 
Abstract 
Early-weaned pigs (n=64) averaging 5.3 ± .3 kg and distributed into two environments 
(dirty and clean) were used to evaluate effects of CLA on growth performance, immune 
competence and empty body composition. A factorial (2 < 4) arrangement within a split-plot 
design with four littermate pigs as the experimental unit for the environment, pig within litter 
as the experimental unit for dietarv' treatment, and d 0 body weight used as a covariate were 
used in data analysis. Diets were formulated to contain CLA at 0. .67. 1.33 or 2% and to 
exceed NRC (1988) nutrient needs of pigs, and were self-fed for 7 wk in three phases (I. I to 
2: II. 3 to 5: and III. 6 to 7 wk). Within phases, diets were isocaloric and isonitrogenous. In 
phase I as CLA concentration increased. ADFI decreased (P<.05) linearly. In phase II. ADG 
increased quadratically (603. 623.622. and 548 g/d: P<.01). ADFI decreased linearly (873. 
840. 867. and 717 g/d; P<.02) and gainrfeed increased linearly (691. 742. 715. and 763; 
P<.07). In phase III. no differences in growth performance were attributed to dietary 
treatments. Pigs in the clean room had a greater cumulative ADG (P<.01) and a greater ADFI 
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(P<.01) than pigs in the dirty room. The greater PUN observed in clean pigs on d 14 (P<.03) 
was attributed to greater protein intake associated with a greater ADFI, of pigs in the clean 
room. On d 42. dietary CLA induced an increase in percentages of CDS'" lymphocytes (21.7, 
22.3. 28.0. and 32.7 %: P<.00l). AGP levels were used as indirect indicators of cytokine-
driven responses, and showed a linear increase on d 14 (P<.02). 28 (P<.01) and 42 (P<.01) as 
dietary CLA increased. On d 42. three pigs per treatment per room were killed, ground, 
sampled and protein, fat and water content were measured. As dietary CLA increased, a linear 
decrease in fat (10.8. 10.5. 9.8. and 8.6 %; P<.07) was obser\'ed. These data suggest that 
dietary CLA supplementation modulates porcine CD8" immune cell phenotype, improves 
feed efficiency and decreases body fat. 
Introduction 
CLA is a mi.xture of positional {9.11; 10.12: or 11.13) and geometric (cis or trans) 
isomers of conjugated octadecadienoic (18:2) acid with broad biological activities. CLA is 
anticarcinogenic (Ha et al.. 1989: Haetal.. 1990: Pariza. l991:Shultzetal.. 1992a; Shuitzet 
al.. 1992b: Ip et al.. 1994a: [p et al.. 1994b: Ip et al.. 1994c: Ip et al.. 1997: and Liu et al., 
1997), antidiabetic (Houseknecht et al., 1998). antiatherogenic (Nicolosi et al.. 1993: Lee et 
al.. 1994) and immunomodulatory (Cook et al.. 1993: Miller et al.. 1994: Wong et al.. 1997: 
Chew et al.. 1997: Bassaganya-Riera et al.. 1998: Sugano et al.. 1998: Bassaganya-Riera et 
al.. 1999: and Hayek et al.. 1999). CLA is a natural product that enhances immune function 
while decreasing, at the same time, the negative effects of inflammatory responses. In the 
European Union, the use of antimicrobials at subtherapeutical levels has been prohibited. In 
the United States, dietary immunomodulation by using namral products might become a 
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strategy adopted by producers as a means to maintain their competitivity after antibiotic 
withdrawal from livestock dietary formulations. 
CLA diminishes both the catabolic response and the decreased growth associated 
with an LPS-induced inflammatory response in chickens and mice (Cook et al.. 1993. and 
Miller et al.. 1994). Thus, the effects of CLA on growth seem to be linked to changes in 
immune or intlammatory profiles. We hypothesized that CLA would enhance cellular 
immunity, and that CLA effects on growth performance and body composition would be 
influenced by the environment. The objectives of this experiment were to determine how the 
health status of the pig influences the response to dietar\' CLA supplementation on growth, 
immune response and body composition. 
IVIaterials and Methods 
Dietary and Management Treatments 
Sixty-four l4-d-old early-weaned pigs averaging 5.3 ± .3 kg were randomly 
distributed from outcome groups based on litter and body weight to eight blocks of four 
contiguous individual pens within environment (dirty or clean). In each environment. 0, .67. 
1.33 or 2% CL.A.-60 isocaloric and isonitrogenous diets were randomly allotted to pens within 
block. Diets were formulated to exceed NRC (1988) nutrient needs of pigs (Table 1), and 
were self-fed for 7 wk in three phases (I. 1 to 2: II. 3 to 5: and III. 6 to 7 wk). Two distinct 
management schemes were used to create the two experimental environments. To create the 
dirty environment, older pigs were introduced into the experimental room 1 wk before 
starting the experiment and no biosecurity rules were applied to this room. To create the clean 
environment, pigs were injected with a third generation cephalosporin (Naxcel; Upjohn, 
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Kalamazoo. MI) every other day from the faaowing date until d 0 of the experiment, and 
biosecurity rules were applied to the clean room during the entire experimental period. 
Data and Sample Collection 
Pigs were weighed and feed intakes were measured weekly to determine ADG. ADFI 
and gain : feed ratio (G:F). Peripheral blood was obtained through vena cava puncture on d 0. 
14. 28 and 42 and collected in 10 ml heparanized evacuated tubes (Monoject, St Louis. MO). 
White blood cells in peripheral blood were counted with a Coulter Particle Counter (Beckman 
Coulter Corp.. Miami. FL) after erythrocyte lysis with whole blood lysis reagents (Coulter 
Immunology. Hialeali. FL). Plasma was separated after centrifugation at 800 x g for 20 min. 
and stored at -20" C until it was analyzed for al-acyl glycoprotein (AGP) with a radial 
immunodiffusion assay and plasma urea nitrogen (PUN) using the colorimetric automated 
technique described by Marsh et al. (1965). 
Table 1. Dietary composition (as-fed basis). 
Control diets 
Ingredient, % Phase, r"' Phase, ir-' Phase. Iir'" 
Com 31.57 50.21 62.18 
Soybean meal (48%) 12.00 21.16 31.16 
Dried whey 22.00 16.00 — 
Spray-dried plasma 7.50 4.00 — 
Dried blood cells 2.00 — 
Dry skim milk 21.00 
— 
— 
CLA-60'^' 
— — 
— 
Soy oil J.JJ 3.33 
DL-Methionine .18 .22 .09 
Sodium chloride .25 .25 .25 
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Table I. (continued) 
Dicaicium phosphate 1.09 1.72 1.95 
Calcium carbonate .78 .81 .74 
Vitamin premi.x""' .20 .20 .20 
Trace mineral"" .05 .05 .05 
Selenium premix .05 .05 .05 
Nutrient composition, % 
Crude protein 24.18 21.20 19.74 
Lysine 1.90 1.66 1.40 
Methionine+cystine .96 .85 .71 
Calcium 1.05 .90 .81 
Phosphorus .87 .79 .73 
Ca:P ratio 1.21 1.14 1.11 
MEkcal/kg 3725 3737 3804 
•'Phase I. vvk 1-2: Phase 11. vvk 3-5; Phase III. wk 6- 7. 
''E.xpressed as CLA-60: 1.12. 2.21. and 3.33 representing .67. 1.33 and 2% CLA 
experimental diets, respectively. CLA-60 contains a 60% CLA in an approximate 50: 50 
mi.xture ofc9. tl l/t9. cl 1 and clO. tl2/ tlO. cI2. 
'^Supplied 4.409 lU vitamin A: 1.102 lU vitamin D3: 22 lU vitamin E; 6.6 mg riboflavin: 
17.6 mg pantothenic acid: 33 mg niacin: and 22 |ig vitamin B12 per kilogram of diet. 
'^Supplied 165 ppm Zn: 193 ppm Fe: 66 ppm Mn: 19.29 ppm Cu: and .2 ppm Iodine per 
kilogram of diet. 
Lymphocyte Blastogenesis Assay 
Complete medium was prepared by supplementing RPMI 1640 with 25mM HEPES 
buffer (Sigma. Saint Louis. MI), 100 units/ml penicillin (Sigma). .1 mg/ml streptomycin 
(Sigma). 5 X 10'^ M 2-mercaptoethanol (Sigma). 1 mM essential amino acids (Mediathech 
Inc.). 1 mM non-essential amino acids (Sigma), 2 mM L-glutamine (Sigma), I mM sodium 
pyruvate (Sigma) and 10% FBS. Media pH were measured with a pH meter (Orion Research 
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Inc.. Beverly. MA) and brought to 7.4 with addition of a solution of 7.5% sodium bicarbonate 
(Fisher Scientific. Pittsburgh. PA). 
Wells of 96-well fiat-bottomed microliter plates (Falcon 3072; Becton Dickinson, 
Lincoln Park. NJ) were seeded with 100 |il of whole blood and 100 }al of either media alone 
(non-stimulated wells) or media containing concanavalin (Con-A) (5 ng/ml) (Sigma). 
Plates were incubated for 5 d at 37° C in 5% COi humidified atmosphere. After 5 d of culture. 
0.5 |iCi of methyl-f H] thymidine (specific radioactivity 6.7 Ci mmol"'; Amersham Life 
Science. Arlington Heights. IL) in 10 |.il of medium was added to each well and plates 
incubated for an additional 20 h. Well contents were harvested onto fiber filters with a PHD 
cell harvester (Cambridge Technology. Cambridge. MA) and incorporated radioactivity 
measured by liquid scintillation counting (Hewlett-Packard. Meriden. CT). Samples were run 
in triplicate and stimulation indices (SI) calculated by dividing counts min"' (cpm) of 
stimulated wells by counts min"' from non-stimulated wells. 
Preparation of Blood for Flow Cytometric Analysis of CD4 and CD8a Surface Expression 
Lymphocytes were analyzed for expression of CD4 and CD8a cell surface antigens by 
flow cytometrv'. A volume of 10 fil of whole blood was added into a round-bottomed 
microliter plate (Becton Dickinson. Lincoln Park. NJ) and stained with 15 ^l of primary 
antibody dilution in phosphate buffered saline (PBS) (1:50): IgG2b mouse anti-swine-CD4 
PE-labeled (74-12-4). lgG2a mouse anii-swine-CD8a FlTC-labeled (76-2-11) (hybridoma 
supematants kindly provided by Dr. Joan K. Lurmey; Beltsville. MD). and appropriate isotype 
control antibodies: mouse IgG2a-Quantum Red (Sigma) for anti-CD8a and mouse IgG2b-PE 
(Sigma) for anti-CD4. After a 30-min incubation, cells were washed twice with PBS and 
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centrifliged 8 min at 200 ^ g in a Beckman TJ-6 centritlige (Beckman Coulter Corp.. Miami, 
FL). Cells were washed with 100 |.il of lysing solution dilution in PBS (1:25) (Immuno-lyse; 
Beckman Coulter Corp.) and 10 |il of fixative solution (Fi.xative liquid reagent: Coulter 
Corp.) was added for a 2-min period. Finally, cells were washed twice and brought to a final 
volume of 500 |.il. A two-color flow cytometric analysis with a Coulter XL (Beckman Coulter 
Corp.) was conducted on lymphocytes. 
Measurement of Plasma Porcine al-acyl glycoprotein (.A.GP) Concentrations 
.A.GP levels were measured with radial immunodiffusion test according to 
manufacturer instructions (Cardiotech Services Inc., Louisville. KY). Briefly, a standard 
curve (250. 500. 750 and 1000 |.ig AGP/ ml) was prepared with appropriate dilution of 
standard solution A (1000 }.ig AGP/ ml) or standard solution B (250 fig AGP/ ml) both 
provided in the measurement kit. A volume of 5 ^ il of each sample was added into one of the 
10 wells contained in each of the test plates. The cover was firmly secured, and incubated in a 
humidified atmosphere at 37° C for a 24-h period. After 24 h. a plastic scale provided with the 
kit was used to measure the e.xtemal diameter of each ring of precipitation. The diameters of 
the samples were converted into AGP concentration values based on the standard curve. 
Measurement of Empty Body Composition 
A total of 24 pigs were killed and necropsied at the end of the experiment to assess 
empty body composition. Gastrointestinal contents were removed; the empty body of the pig 
was sawed into pieces and ground once through a 12.5 mm plate and once through a 6.5-mm 
plate of a large-size grinder. After grinding, the groimd tissue was mi.xed by hand to 
maximize homogeneity. Two 200-g samples of ground tissue were obtained. Water content of 
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the empty body was determined by freeze-drying samples to a constant weight. Tissue 
samples were then dried in a 100° C oven. Protein was determined with the Kjeldahl method 
(AO AC. 1990). Fat was determined using an ether extraction procedure described by AO AC 
(1990). 
Experimental Design 
The experiment was designed as a split-plot design with pig within block being the 
experimental unit for dietary treatment (sub-plot) and eight blocks of four littermate pigs 
within room being the experimental units for environmental treatment (whole plot). 
Statistical Analysis 
Data were analyzed as a 2 ^ 4 factorial arrangement of treatments within the split-plot 
design using the general linear model (GLM) procedure of SAS (1988) (SAS Institute Inc., 
Cary. NC). ANOVA and linear and quadratic contrasts were analyzed. Significance was 
assessed at P <.05. 
Results 
Growth Performance 
An interaction (P<.01) was described between environment and dietary treatment only 
on phase I. In the dirty room, pigs fed CLA had lower ADO and ADFI than control pigs but 
in the clean room that decrease was not observed. In phase II. as dietary CLA increased. ADG 
increased and then decreased quadratically (603.623.622. and 548 g/d; P<.01), ADFI 
decreased linearly (873. 840. 867. and 717 g/d; P<.02) and gainrfeed increased linearly (691, 
742. 715. and 763: P<.07). In phase III. no differences in growth performance were attributed 
to dietary treatments. Through the entire experiment, differences in ADG and ADFI were 
attributed to the environment. Pigs in the clean room grew faster and ate more than did pigs in 
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the dirty room. Pigs in the clean environment had a greater phase I (P<.0001). phase II 
(P<.0001) and cumulative (P<.01) ADG than pigs in the dirty environment. Also. ADFI in 
phases 1 (P<.001). II (P<.005) and cumulative (P<.01) were greater in pigs exposed to a clean 
environment than in pigs exposed to a dirty environment (Table 2). 
Table 2. Effect of CLA and environment on growth performance of weanling pigs'*'*. 
Environmental treatments 
Item phase'' CL/ 
Dirty Clean 
SEM"-' 
P value*^ 
V,% 0 .67 1.33 2 0 .67 1.33 T L Q 
ADG.g I 245 158 197 168 275 286 342 224 19 .02 .21 
II 576 593 558 473 630 653 685 623 26 .05 .01 
III 764 735 767 740 789 764 810 820 24 .54 .60 
Cum. 535 509 514 462 575 580 617 565 15 .04 .06 
ADFl.g I 296 197 228 216 341 325 419 275 24 .05 .56 
II 835 795 799 625 910 885 935 809 55 .02 .15 
III 1295 1227 1289 1213 1249 1190 1319 1221 47 .65 .73 
Cum. 810 745 772 616 849 820 892 804 42 .04 .25 
G:F I 828 802 864 778 806 880 816 815 74 .49 .96 
II 690 746 698 757 692 738 733 770 117 .07 .65 
HI 590 599 595 610 632 642 614 672 47 .32 .36 
Cum. 660 683 666 750 677 707 692 703 124 .11 .43 
•'Least squares means. 
''An environment x diet interaction was described on phase I for ADG (P<.01) and ADFI 
(P<.01). 
•^P-value of a linear (L) and quadratic (Q) effect of dietary treatment. 
''Phase I. wk 1 to 2; ph II. wk 3 to 5: ph III, wk 6 to 7; and cumulative (cum), wk 0 to 7. 
'Subplot SEM. 
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Lymphocyte Phenotype and Function 
On d 42. as the level of CLA in the diet increased, a linear increase in percentages of 
lymphocyte subsets contained in the CD4'CD8'' lymphocyte population (P<.001) and in 
TCRapCD4"CD8aa T lymphocytes (P<.06) were observed. Also. TCRapCD4^(P<.02) T 
cells percentage decreased linearly as the CLA content was augmented, although numerically 
the decrease in CD4' lymphocytes was not as large as the increase in CD8^ lymphocytes 
(Table 3). 
Table 3. Effcct of CLA and environment on porcine lymphocyte subsets phenotype 
(% of total lymphocytes)"''. 
Environmental treatments'^ 
Dirty Clean P value*' 
Phenotype CLA,% 0 ^7 \l3 T "O H LTJ 2 SEM' T Q 
TCRapCD4' 27.0 27.1 27.4 24.1 27.5 24.9 24.6 21.3 1.70 .02 .41 
TCRapCD4TD8aa 7.2 8.9 9.7 11.8 6.9 7.0 10.4 9.1 1.69 .06 .83 
CD4*CD8^ subsets' 21.9 23.1 24.3 29.0 21.6 21.4 31.7 36.3 1.80 .0001 .13 
CD4-CD8"-- 45.4 43.1 37.3 33.4 43.6 47.6 31.9 31.9 2.40 .0001 .37 
''Least squares means. 
''An environment x diet interaction (P<.03) was described on CD4'CD8'" subsets. 
'^Pigs in the clean room had greater percentages (P<.02) of CD4"CD8'" subsets than dirty 
room pigs. 
''P-value of a linear (L) and quadratic (Q) effect of dietary treatment. 
'"Subplot SEM. 
'The CD4"CD8" cell subset includes TCRySCDSaa. CD3"CD16^CD8aa (NK cells), 
TCRapCDSap. and putatively TCRapCDSaa T cells. 
=This lymphocyte fraction includes B cells and TCRY6CD8aa" lymphocytes 
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An environment x diet interaction (P<.03) was described on CD4"CD8^ subsets which 
indicated that the CLA-induced increase in percentages of CD4'CD8^ cells was greater in 
pigs found in the clean room. .Also, pigs in the clean room had greater percentages (P<.02) of 
CD4'CD8'" subsets than did pigs in the dirty room. No differences caused by dietary CLA 
supplementation were found in cells proliferating in response to Con-.A addition into the 
media (data not shown). However, in the non-stimulated (non-stim) wells (media alone) pigs 
fed CLA had a greater proliferative response, measured as methyl-["'H] thymidine 
incorporation, than pigs fed a control diet on d 14 (P<.04 L) and 28 (P<.07 Q) (Table 4). On 
d 42. proliferation of cells from pigs in the dirty environment was greater (P<.01) than in 
cells obtained from clean environment pigs. 
Table 4. Effect of CLA on the porcine lymphocyte proliferation"'' (cpm in non-
stimulated wells'^). 
Environmental treatments 
Dirty Clean 
SEM*' 
P value'^ 
Day CLA, % 0 .67 1.33 2 0 .67 1.33 2 L Q 
14 742 1054 1471 2041 947 600 1518 916 353.1 .04 .99 
28 1025 1792 2135 1091 1185 1249 2052 1356 481.1 .57 .07 
42 881 523 801 604 315 632 437 357 146.6 .53 .58 
"^o environment x diet interaction. 
'^Methyl-[''H] thymidine incorporation in proliferating lymphocytes. 
''On d 42. lymphocyte proliferation of pigs in the dirty environment was greater (P<.01) than 
that of pigs located in the clean environment. 
•^P-value of a linear (L) and quadratic (Q) effect of dietary treatment. 
'Subplot SEM. 
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On d 14 and 42. a trend towards an increase in white blood cell (WBC) counts, which 
included lymphocytes, neutrophils, eosinophils, basophils and monocytes, as dietary CLA 
increased was found (P<.09 Q) and (P<.09 L). respectively, regardless of the room (Table 5). 
That increase was probably caused by increased numbers of lymphocytes. 
Table 5. Effects of CLA on WBC counts"''. 
Environmental treatments'^ 
Dirty Clean P value*' 
Day CLA, % 0 .67 1.33 2 0 .67 1.33 2 SEM'^ L Q 
14 38.0 42.1 38.3 32.6 14.8 18.1 13.9 16.3 2.31 .17 .09 
28 26.6 28.9 24.0 21.6 23.6 25.1 20.7 31.0 3.37 .92 .67 
42 19.6 24.5 22.9 17.4 45.3 36.4 41.3 35.8 2.84 .09 .40 
^Least squares means. 
^^o environment x diet interaction. 
"•"On d 14. dirty room pigs had greater WBC counts than clean room pigs (P<.0001) and. on d 
42. clean room pigs had greater WBC counts (P<.0001) than dirty room pigs. 
''P-value of a linear (L) and quadratic (Q) effect of dietary treatment. 
'Subplot SEM. 
Empty Body Composition 
Empty body composition analyses of killed pigs indicated that pigs fed CLA had a 
trend towards lower percentages of body fat (P<.07) (Table 6) than control animals did. The 
percentage of fat in pigs from the clean room was greater (P<.009) than that of pigs in the 
dirty room. An environment diet interaction tor water content (P<.02) suggested that, in the 
dirty room, pigs fed CLA had greater water content than pigs fed CLA in the clean room. Pigs 
in the dirty room had greater water percentages (P<.005) than pigs in the clean room. 
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Table 6. Effects of CLA and environment on empty body composition, 
Environmental treatments'^ 
Dirty Clean P value** 
Item, CLA, % 0 .67 1.33 2 0 .67 1.33 2 SEM" L Q 
Protein 16.1 15.8 17.0 15.1 16.4 19.2 15.8 16.3 .90 .52 .33 
Fat 9.7 8.4 10.0 6.8 11.9 12.5 9.6 10.4 .70 
o
 
q
 
Water 74.5 74.9 71.5 75.6 70.4 70.4 74.5 71.8 .60 to
 
o
 
"Least squares means. 
^An environment x diet interaction (P<.02) for fat content was described. 
"^Fat content was greater (P<.009) in pigs of the dirty room. 
""P-value of a linear (L) and quadratic (Q) effect of dietary treatment. 
'•"Subplot SEM. 
Plasma AGP Concentration 
No environment x diet interaction was found for plasma AGP levels. Throughout the 
experiment, pigs fed CLA had greater levels of plasma .AGP than pigs fed a control diet 
(Table 7). On d 28 and 42 pigs in the dirty room had greater plasma AGP (P<.01) and 
(P<.000l) respectively, than did pigs in the dirty room. 
Plasma Urea Nitrogen Levels 
On d 14 and 28. pigs in the clean room had greater PUN levels (P<.03) and 
(P<.0006). respectively, than pigs in the dirty room. Overall, dietary CLA did not influence 
PUN levels (Table 8). However, on d 14. an environment ^ diet interaction (P<.06) indicates 
that in the clean room CLA numerically decreases PUN levels but. in the dirty room, CLA 
does not modify PUN levels. 
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Table 7. Effects of CLA on plasma AGP concentration ({ig/ml)"''. 
Environmental treatments' 
Dirty Clean P value** 
Day CLA, % 0 .67 1.33 2 0 .67 1.33 2 SEM' L Q 
14 970 825 982 1056 726 745 I 140 1261 156.6 .02 .28 
28 626 652 779 1145 475 520 658 848 58.1 .0001 .004 
42 
ar _ . 
612 584 574 854 448 475 496 616 32.7 .0001 .0001 
environment x diet interaction. 
'"On d 28 and 42 pigs in tiie dirty room had greater plasma AGP (P<.01) and (P<.000l) 
respectively, than did pigs in the clean room. 
''P-value of a linear (L) and quadratic (Q) effect of dietar\' treatment. 
•••Subplot SEM. 
Tabic 8. Effects of CLA and environment on plasma urea nitrogen (mg/dl 
Environmental treatments'" 
Dirty Clean P value** 
Day CLA,% 0 .67 1.33 2 0 .67 1.33 2 SEM*-" L Q 
~R 10.3 13.5 9.8 11.0 14.8 12.0 11.9 12.2 TOO .14 .75 
28 8.8 9.6 8.5 9.7 13.4 14.3 12.5 10.5 1.33 .56 .30 
42 13.5 14.2 13.8 12.5 13.2 12.9 12.8 9.7 1.36 .11 .30 
•'Least squares means. 
''.\n environment x diet interaction (P<.06) was described on d 14. 
"^PUN levels on d 14 and 28 were greater (P<.03) and (P<.0006). respectively, in pigs of the 
clean room. 
''P-value of a linear (L) and quadratic (Q) effect of dietary treatment. 
'Subplot SEM. 
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Discussion 
Growth Performance. Previous data show that the effects of CLA on feed efficiency 
were not consistent from one experiment to the other. CLA tended to improve feed efficiency 
in finisher gilts (Dunshea et al.. 1998). Sparks et al. (1999) showed a quadratic improvement 
in feed efficiency in response to dietary CLA in grower-finisher pigs. However. Eggert et al. 
(1999) indicate that feed efficiency was not affected by feeding CLA to two genotypes of 
lean gilts. The quality of the source of CLA used, the composition of the basal diet, health 
status, and the environmental conditions in which the experiment is held are variables that 
will potentially influence the final outcome. We have shown that CLA improved feed 
efficiency in phase 11. regardless of the environment. However, in phase [. CLA decreased 
ADG and ADFl of pigs in the dirty room. Although CLA induced an enhancement in cellular 
immunity after 40 d. that future enhancement in the immune response will not have an 
immediate benefit to pigs exposed to an environment contaminated with pathogens from 
older pigs. 
In phases 1 and II. pigs in the dirty room had lower .^DFl than pigs in the clean room, 
which relates to the lower PUN levels found on d 14 and 28 in pigs in the dirty room. The 
reason being that pigs in the dirty room, as a consequence of their decreased feed intake, will 
also decrease the intake of protein. 
Body composition. In our experiment, dietary CLA only slightly modified body 
composition of the pigs by decreasing the percentage of fat. Two month-old pigs, which are 
mainly deposiung lean mass during growth, will show less pronounced dietary-induced 
differences in fat content than grower-tlnisher pigs. 
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Immune Competence. We showed a trend towards an increase in WBC counts due to 
CLA supplementation, which is consistent with earlier work conducted by Cook et al. (1998). 
In the light of the lymphocyte phenotype data showing increased percentages of certain 
lymphocyte subsets, the increase in WBC counts could be attributed to an increase in the 
total number of lymphocytes. In swine. CDS' lymphocytes represent the numerically larger 
peripheral lymphocyte sub-population. We have shown for the first time that, after a period 
of feeding CLA. percentages of TCRapCD4''CD8aa T cells and CD4'CD8' cell subsets 
were linearly increased. The latter phenotype includes distinct cell subsets with different 
functions: CD3" CD16"CD8aa lymphocytes (NK cells). TCRapCDSaP T cells (cytotoxic T 
lymphocytes). TCR.y6CD8aa T cells and putatively TCRapCD8aa T cells. The type of 
dietary immunoenhancement induced by CLA and. therefore, the diseases that CLA could 
contribute to prevent depend on the function of the CD8' cell subset most influenced by 
dietary CLA. In future e.\periments we are planning to further characterize both 
phenotypically and functionally the nature of the cell subsets most affected by dietary CLA 
supplementation. 
We have shown that lymphocytes from pigs fed CLA proliferate more in culture 
without mitogen stimulation tlian do lymphocytes from control pigs. Wong et al. (1997) and 
Hayek et al. (1998) described an increase in interleukin-2 (IL-2) production in murine splenic 
lymphocytes. IL-2. which is a T cell growth factor, could be involved in the enhanced 
proliferation of lymphocytes from pigs fed CLA. Our AGP data, an indirect indicator of IL-2 
production, are also consistent with a role of CLA in regulating cytokine production because, 
throughout the experiment, pigs fed CLA had greater levels of plasma AGP than did control 
pigs. However, based on the findings indicating that CLA has antiinflammatory properties 
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(Cook et al.. 1993) we can conclude that increased plasma AGP concentrations was not 
synonymous of increased pro-inflammatory cytokine production. Therefore, AGP levels 
alone are not reliable indicators of either immune responsiveness or health status, and AGP 
data should be interpreted in tlie context of other immunological assays. CLA decreases 
prostaglandin E: (PGE2) production (Belury et al.. 1997) by interfering in the metabolism of 
linoleic acid into arachidonic acid, which is the precursor for the synthesis of 2-series 
prostaglandins and 4-series ieukotrienes. PGEi was demonstrated to be suppressive to the 
cellular arm of immunity (Goldyne and Strobo. 1982) and to decrease IL-2 production (Roitt 
et al.. 1998). Therefore, the CLA-derived decrease in PGE: might diminish the negative 
impact that PGE: elicits on cellular immunity and lL-2 production. CLA might also modulate 
cytokine production and immune function through peroxisome proliferator-activated 
receptors (PPAR) ligation. Houseknecht et al. (1998) showed that dietary CLA is associated 
with elevated levels of a number of genes that are responsive, in part, to PPAR-y. Also. CLA 
has structural and physiological characteristics similar to peroxisome proliferators (Su et al.. 
1999) and is able to activate PPARs while not being a peroxisome proliferator (Moya-
Camarena et al.. 1999). As PPARs are involved in modulating the activities of important 
transcription factors that regulate cytokine expression (Ricote et al.. 1998). that could also 
explain why CLA causes peripheral CD8^ lymphocyte expansion and modulates cytokine 
production. 
[mplications 
Dietary CLA increases porcine CD8^ lymphocyte subsets and enhances overall 
lymphocyte proliferation in both clean and dirty environments. Thus, CLA is a cellular 
100 
immune enhancer that could be used to improve, at the cellular level, vaccination efficacy and 
to control diseases where CD8^ cells are critical. 
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CHAPTER 3. DIETARY CONJUGATED LINOLEIC ACID-INDUCED 
PHENOTYPIC AND FUNCTIONAL MODULATION OF CD8* CELL SUBSETS 
VERSUS BACTERIAL ANTIGEN-DERIVED CELLULAR REGULATION 
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Josep Bassaganya-Riera. Raquel Hontecillas-Magarzo. Michael J. Warmemuehler. 
and Dean R. Zimmerman 
Abstract 
The heterogeneity of the porcine CDS" lymphocyte subpopulation. which contains 
distinct cell subsets, makes pigs good models for functional and phenotypic investigations on 
CDS" cells. In contrast to that, a more uniform CDS expression pattern described in humans 
complicates the study of differences among CDS" subsets. Biological enhancers of the 
numbers of CDS' cells might improve the knowledge of the role of CDS" cells in cellular 
immunology. Conjugated linoleic acid (CLA) is a mixture of positional (9. 11; 10. 12; or 11. 
13) and geometric (cis or trans) isomers ofoctadecadienoic acid that decreases prostaglandin 
Et (PGEi) production by modulating arachidonic acid (AA) metabolism. While other 
antiintlammator\' agents decrease eicosanoid production but do not affect CDSa expression, 
CLA does. We hypothesized that the CLA-induced expansion of CDS" cells involves distinct 
CDS"^ cell subsets and enhances specific CD8"-related functions. Here, we confirmed our 
preliminary findings by showing a CLA-dependent increase in CDS" lymphocytes. 
Furthermore, we report for the first time, an observation that links a nutritional supplement to 
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increased CD8a expression. CLA causes in vivo expansion of peripheral TCRY5CD8aa T 
cells. CD3'CD16^CD8aa lymphocytes (NK cells) and TCRapCDSap T cells pre-cytotoxic T 
lymphocytes (pre-CTLs). Interestingly, the CLA-induced expansion of peripheral 
TCRapCDSap cells was consistent with increased percentages of TCRapCDSaP and double 
negatives thymocytes, whereas thymic CD8aa^ subpopulations percentages were unaffected 
by dietary CLA. Moreover, these phenotypic changes are functionally related to an 
enhancement in effector CTL cytotoxicity. Collectively, these data suggest that dietary CLA 
causes in vivo expansion of CDS" cells involved in both adaptative and innate immunity. 
Introduction 
Immunological concepts are sometimes developed without taking into consideration 
the influence that external factors such as diet, environment or genetics elicit on the animal 
host that is the source of experimental biological material (e. g.. lymphocytes, cytokines, 
nuclear transcription factors). substantial amount of work has been completed regarding the 
impact of dietar\' fatty acids in eicosanoid production (Calder. 1996. 1998). or more recently, 
the fatty acid-induced transcriptional regulation of cytokine gene expression (Jiang et al.. 
1998). both related to regulation of the immune response. However, the lack of specific 
studies addressing the effects of nutrients on the phenotype of distinct T cell subsets has 
particularly limited the understanding of the mechanisms of action of nutrients at the cellular 
and molecular levels. For instance, to induce a measurable expansion of cells within a 
particular phenotype in vivo, antigen-induced lymphocyte stimulation represents the 
traditional immunological tool, in which the pathway of antigen presentation plays an 
important role. This approach is supported by the clonal selection theory (Burnet. 1959) 
which has been utilized to explain the expansion of nai ve lymphocytes into clones of antigen-
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specific effector lymphocytes and has become one of the main pilars of cellular immunology. 
We propose a novel approach, which is nutritional in nature, to modulate the phenotype of 
particular lymphocyte subsets in vivo. The modification of T cell phenotype through a 
nutritional intervention differs from reponses derived from antigenic challenge on that 
expanded cell subsets cannot be described as specific for one single epitope. The impact on 
CD8' cellular immunity of a mixture of positional (9. II: 10. 12; or 11. 13) and geometric 
(cis or trans) isomers of octadecadienoic (18:2) acid known as CLA will be described here in 
detail. CLA is a nutrient with broad biological activity and is known to be anticarcinogenic 
(Haetal.. 1989: Ha et al.. 1990: Pariza. 1991:Shultzet al.. 1992a: Shultzetal.. 1992b: Ipet 
al.. 1994a: Ip ct al.. 1994b: Ip et al.. 1994c: Ip et al.. 1997: and Liu et al.. 1997). antidiabetic 
(Houseknecht et al.. 1998). antiatherogenic (Nicolosi et al.. 1993: Lee et al.. 1994). and 
immunomodulator (Cook et al.. 1993: Miller et al.. 1994: Wong et al.. 1997: Chew et al., 
1997: Bassaganya-Riera et al.. 1998: Sugano et al., 1998: Bassaganya-Riera et al., 1999: and 
Hayek et al.. 1999). Currently, there are no studies relating the role of CLA-induced 
enhancement of a particular lymphocyte subset to tumor immunology. Although CLA has 
been shown to increase IL-2 production in vivo (Hayek et al.. 1999). the lack of a cellular 
basis in CLA research indicates that the mechanistic understanding of its functional role as an 
anticarcinogen is in a very immature stage. In humans and mice, abundant data suggest that 
CD8^ cells may have an essential role in antitumor immunity. 
Both CTLs and natural killer (NK) cells bear the CD8 molecule on their surface. In 
most mammalian species. CDS molecules are expressed either as a disulfide-linked aa-
homodimer or as an ap-heterodimer on the surface of lymphocytes (Norment et al., 1988). In 
humans, thymocytes and most mature peripheral lymphocytes preferentially express the 
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CD8aP molecule, but on a subset of NK cells and intraepithelial lymphocytes (lEL) only the 
CDSaa form is present (Sun et al.. 1997). The functional significance of the tissue-dependent 
CDS expression patterns in lymphocytes is not entirely known. 
In humans, most recirculating CDS" lymphocytes are phenotypically TCRapCDSaP 
cells which are. functionally, resting or quiescent cells (pre-CTLs) containing granzymes and 
other lytic molecules within their lytic granules. Pre-CTLs have the potential to become, upon 
appropriate TCR/CD3 complex stimulation, degranulating activated effector cells (CTLs). In 
human immunology, the term CTL or pre-CTL is indeed used synonymously with CDS 
lymphocyte. A weakness of the human model of CDS research derives from the uniformity of 
that cell subset, which is reflected by the predominance of TCRapCDSapCDlS''"" T cells 
which express CD 18. a p: integrin used for endothelial adherence, at low densities might 
mask the functional role of other CDS" subsets. For instance, because the human 
TCRapCDSapCDlS''^'^'" cell subset is a very reduced peripheral cell subset compared v^-ith 
TCRapCDSapCDlS"*"". detection of IL-12 induced activation of the first subset was masked 
by non-responssiveness of the latter (Gollob et al.. 1998). In contrast to what happens in 
humans, porcine CDS" lymphocytes represent a cell population that is both functionally and 
phenotypically heterogeneous, in which CDSaa expression predominates in thymocytes and 
mature peripheral lymphocytes (Pescovitz et al.. 1994; Zuckermarm and Husmann, 1996; 
Summerfield et al.. 1996; Zuckermann et al.. I99S). Phenotypically. porcine CDSaa" 
lymphocytes can be further subdivided into TCRy6"CD4". TCRaP^CD4". or CD3'CD16* 
(natural killer) and putatively. according to indirect inferences (Yang and Parkhouse, 1996) 
TCRaP"CD4". All CDSaP" T cells bear the TCRaP on their membrane. The enormous CDS 
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hetereogeneity described in pigs, wliich contrasts with the uniform CDS pattern described in 
humans or mice, facilitates the detection of small changes in a broad range of both peripheral 
and tissue-specific CD8^ lymphocyte subsets. Therefore, based on that peculiarity, pigs are 
good models for studies of several aspects of cellular immunology, particularly those related 
to the surface expression of CD8a in lymphocytes. 
Our studies were designed to determine the effects of CLA on phenotype and function 
of CDS'" lymphocyte subsets and to better understand how these populations regulate or are 
regulated by the immune response induced by an ongoing bacterial antigenic challenge. Based 
on our previous studies, which indicated that peripheral CDS^ cells linearly increased as we 
increased the amount of CLA in tlie diet (Bassaganya-Riera et al.. 1999). we proposed that 
CLA would increase distinct CDS" lymphocyte subsets and that might influence lymphocyte 
function. In our preliminary experiments, to study how CL.A influenced T cell phenotype. 
CD4 and CDSa surface expression was assayed on peripheral lymphocytes (Bassaganya-
Riera et al.. 1999). In the studies reported here, we have assayed for peripheral blood 
mononuclear cell (PBMC) surface expression of CDSa or CDSp along with the necessary 
surface markers to further phenotypically characterize all the distinct CDS'" cell subsets (e.g.. 
6 chain of TCR. CD16. CD4 and CD3). A model of vaccination with an extracellular bacterial 
antigen (proteinase-digested Brachyspira hyodysenieriae B204 strain bacterin) that causes 
clonal selection and expansion of CD4^ T cells which, in turn, are responsible for a cytokine-
driven expansion of CDSaa cells, was adopted to evaluate how the non-specific increase in 
lymphocyte subsets induced by dietary CLA modifies and /or interacts with a bacterial 
clonally-derived antigen-specific immune response. 
1 1 0  
Materials and Methods 
Dietary and Vaccination Treatments 
Thirty-two 14-d-old cross-bred pigs were randomly distributed from outcome groups 
based on litter, body weight and sex to blocks of two contiguous individual pens. Either a 
control or a 1.33% CLA isocaloric and isonitrogenous diet was randomly allotted to pens 
within block. On d 21. 28 and 42 four blocks of two pigs each were intramuscularly 
inoculated with 2 ml of a proteinase-digested (PD) B. hyodyseniehae strain B204 bacterin in 
squalene. and four blocks of two pigs each were inoculated with 2 ml of a squalene adjuvant 
preparation alone. Briefly, the squalene adjuvant preparation contained 88% phosphate 
buffered saline (PBS). 10% squalene/pluronic acid (80/20: v:v) and 2% Tween 80. 
Harvesting of Peripheral Blood Mononuclear Cells (PBMC) 
Peripheral blood was obtained through vena cava puncture on d 0. 14. 28.42.49. 56. 
63 and 72. PBMC were isolated by gradient centrifugation. Peripheral blood was diluted 1:4 
(v/v) in PBS. overlayed onto lymphocyte separation medium (Mediatech Inc. Hemdon. VA) 
and centrifuged at 400 ^ g for 40 min. PBMC were obtained from the separation 
medium/plasma interface with a Pasteur pipette, washed three times with PBS, and counted 
with a hemocytometer (Coulter Particle Counter: Beckman Coulter Corp.. Miami, FL) for use 
in phenotypic and functional assays. The remaining peripheral blood was saved for later total 
white blood cell (WBC) after erythrocyte lysis with whole blood lysis reagents (Coulter 
Immunology. Hialeah. FL) and differential counts were conducted with a blood smear and 
staining with Hema 3 Stain Set (Fisher Scientific. Pittsburgh. PA). 
I l l  
Isolation of Mucosal Lymphocytes and Thymocytes 
Large intestine and small intestine intraeptithelial lymphocytes (lELs) and lamina 
propia lymphocytes (LPLs) were isolated using a modification of a previously described 
procedure (VanCott et al.. 1994). Briefly, on d 35. four control pigs (two vaccinated and two 
non-vaccinated) and four pigs fed CLA (two vaccinated and two non-vaccinated) were killed 
and necropsied. Sections (15 cm) of large and small intestine were removed, opened 
longitudinally, and cut into 1 cm pieces totaling 10 to 15 g. Sections were rinsed with Hank's 
balanced salt solution without Ca^' and Mg'" (HBSS. Sigma. St Louis. MO), placed into 
flasks containing 15 ml of HBSS with 5 mM ethylenediamine tetraacetic acid disodium salt 
dihydrate (EDTA. Sigma) and 0.29 |ag/ml dithiothreitol (DTT. Sigma), incubated for 15 min 
at 37° C with constant stirring, and supematants harvested for lEL isolation. Remaining tissue 
fragments were rinsed with RPMl 1640 (Mediatech Inc.) followed by three incubations in 15 
ml RPMl containing 0.25 mg/ml DNase (Boehringer Mannheim: Indianapolis. IN), 300 U/ml 
collagenase (Sigma). 5% heat-inactivated (56° C for 30 min) fetal bovine sera (FBS; 
HyClone. Logan. UT). 200 niM HEPES (Sigma), at 37° C for 15 min with constant stirring. 
Supematants were collected after each incubation for isolation of LPL. Isolation of lEL and 
LPL from supematants was by discontinuous Percoll (Sigma) gradient centrifugation. Briefly, 
supematants were centrituged at 250 x g for 10 min and cells resuspended in 45% Percoll. 
Cells in 45% Percoll were overlayed onto 80% Percoll and centrifiiged at 400 x g for 40 min 
at 4° C. lEL and LPL were harvested from 45 to 80% interface, washed twice in PBS, and 
counted for use in immunophenotyping. To isolate the thymocytes a 3 cm" sample of thymus 
was removed from the necropsied pigs, the tissue was disrupted between two glass surfaces in 
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cold HBSS. the cell suspension was washed twice, and lymphocytes counted on a 
hemocytometer for use in immunophenotyping. 
Lymphocyte Blastogenesis Assay 
Complete medium was prepared by supplementing R.PMI 1640 with 25mM HEPES 
buffer (Sigma). 100 units/ml penicillin (Sigma). O.l mg/ml streptomycin (Sigma), 5 >« 10'' M 
2-mercaptoethanol (Sigma). 1 mM essential amino acids (Mediathech Inc.), 1 mM non­
essential amino acids (Sigma), 2 mM L-glutamine (Sigma). 1 mM sodium pyruvate (Sigma) 
and 10% FBS. Media pH was measured with a pH meter (Orion Research Inc.. Beverly. MA) 
and brought to 7.4 with addition of a solution of 7.5% sodium bicarbonate (Fisher Scientific). 
Wells of 96-vvell tlat-bottomed microtiter plates (Becton Dickinson. Lincoln Park. NJ) 
were seeded with 2 < 10' mononuclear cells in a total volume of 200 |al per well. Wells 
contained either B. hyodyscnteriae antigen whole cell sonicate (5 |.ig/ml. WCS) or (5 |j.g/ml. 
PD) or concanavalin A (5 |.ig/ml, Con-A; Sigma), or medium alone (non-stimulated). Plates 
were incubated for 5 d at 37° C in 5% COi humidified atmosphere. After 5 d, 0.5 |aCi of 
methyl-[''Hl thymidine (specific radioactivity 6.7 Ci mmof': Amersham Life Science. 
Arlington Heights. IL) in 10 |.il of medium was added to each well and plates incubated for an 
additional 20 h. Well contents were harvested onto fiber filters with a PHD cell harvester 
(Cambridge Technology. Cambridge. MA) and incorporated radioactivity measured by liquid 
scintillation counting (Hewlett-Packard, Meriden. CT). Treatments were run in triplicate and 
stimulation indices (SI) calculated by dividing counts min*' of stimulated wells by coimts 
min"' from non-stimulated wells. 
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CD8^ Subpopulations Proliferation Assay 
A total of 2 :< 10^ PBMC were separated to perform PKH2-GL proliferation assays 
(Sigma). Cells were centrifuged (400 x g) for 5 min, supematants aspirated and cells 
resuspended in 1 ml of diluent C (Sigma). Cells, in diluent C. were added to 1 ml of the 
membrane intercalating agent PKH2 (4 -< lO'** M) (Sigma), which is a green fluorescent dye. 
and incubated 5 min followed by a 1 min incubation with 2 ml of FBS to stop the reaction. 
Cells were washed three times with RPMI 1640. Then, stained PBMC were counted in a 
Coulter Particle Counter. PBMC numbers were adjusted to be at a concentration of 2 x 10^ 
PBMC/ml complete media. Standarized cell suspensions (100 |.il) were added to a 96-well flat 
bottomed microtiter plate containing 100 |il of medium (non-stimulated), medium plus 5 
|.ig/ml of a WCS B. hydysentcriae bacterin. medium plus 5 |.ig/ml of a PD B. hyciysentericie 
bacterin. or medium plus 5 |.ig/ml of Con-A. Treatments were run in replicates of six for each 
animal and ex vivo treatment. Cells were incubated at 37" C in 5% COt humidified 
atmosphere for 6 d. After a 6-d period, cultured cells from the six wells of the same ex vivo 
treatment and pig were pooled and prepared for immunophenotyping of the distinct CD8^ cell 
subsets. 
Preparation and .Analysis of Cells for Flow Cytometric .Analysis of Surface Antigen 
E.xpression. 
Mononuclear cells either coming directly from PBMC. thymic or mucosal isolation or 
resulting from a 6-d culture and stained with PKH2. were analyzed for expression of cell 
surface antigens by flow cytometry. Non-cultured cells (2 < lOVml) were resuspended in 100 
fil of balanced salt solution with 1% FBS and 0.04% sodium azide (FACS buffer). Cultured 
cells were directly transferred into the plate for surface antigen staining to avoid membrane 
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damage. Both cultured and non-cultured cells were stained with a volume of 50 |il of the 
primary antibody dilution to swine leukocyte surface antigens: IgG2b mouse anti-swine-CD4 
PE-labeled (74-12-4). lgG2a mouse anti-swine-CD8a biotinylated (76-2-11) (hybridoma 
supematants kindly provided by Dr. Joan K. Lurmey; Beltsville. MD). IgG2a mouse anti-
swine-CDSp (PG164A) (VMRD Inc. Pullman. WA), IgGl mouse anti-swine-CD3 (8E62) 
(VMRD Inc). IgGl mouse anti-swine-TCRyS (PGBL22A) (VMRD Inc). IgGl mouse anti-
swine-PNK-E and IgGl mouse anti-swine-CD 16 (G7) (both NK markers were kindly 
provided by Dr. Yoon B. Kim: Chicago. IL) and appropriate isotype control antibodies: 
mouse IgG2a-Quantum Red (Sigma) for anti-CD8a and anti-CDSp. mouse IgG2b-PE 
(Sigma) for anti-CD4. and a primary mouse IgGl unlabeled (Southern Biotechnology Inc.) 
followed by a secondary goat anti mouse IgGl-PE (Sigma) for anti-CD3. anti-TCRy6. anti-
CD 16. and anti-PNKE. After a 15 min incubation, cells were washed with FACS buffer and 
resuspended in 50 |.d volume of secondary antibody dilution (PE-conjugated goat anti-mouse 
IgGl (Southern Biotechnology Associates Inc.. Birmingham. .'VL) for 8E62. G7. PNK-E and 
PGBL22A. streptavidin-conjugated CyChrome (Pharmingen. San Diego, CA) for biotinylated 
76-2-11. PE-conjugated goat anti mouse IgG2a (Southern Biotechnology Associates Inc.) for 
the PG164A. Cells were incubated for 15 min. washed twice and analyzed by flow cytometry. 
In cultured and PKH2 stained cells, the three-color flow cytometric data aquisition was 
conducted in a F.A.CScan (Becton Dickinson. San Jose. CA). because we have found that 
Coulter XL flow cytometers (Beckman Coulter Corp.) do not provide an accurate flow 
cytometric analysis of cultured proliferating cells stained with PKH2 (Harkins et al., 1999). 
Analysis of data aquired using FACScan was performed using the CellQuest software 
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(Becton Dickinson). Two-color flow cytometric analysis with a Coulter XL was conducted on 
non-cultured and non-stained peripheral or tissue-specific lymphocytes (all lymphocytes 
except those used in PKH2 proliferation assay). 
Granzyme Functional Assays 
Wells of 96-well flat-bottomed microliter plates (Becton Dickinson) were seeded with 
2 X 10"^ mononuclear cells in a total volume of 200 (il per well. Wells contained either B. 
hyoJysenieriue antigens (5 |.ig/ml. WCS) or (5 [ig/ml. PD) or Con-A (5 |.ig/ml). or medium 
alone (non-stimulated). Plates were incubated for 5 d at 37° C in 5% CO2 humidified 
atmosphere. After 5 d. anti-CD3 mAb (8E62) was added into each well at a concentration of 5 
Lig/well. At 6 d. the cultured cell suspension was harvested, centrifuged (400 x g) for 5 min 
supernatant was separated from pellet. Anti-CD3 addition causes cytotoxic activity and cell 
death, regardless of the presence of lL-2 (Wang et al.. 1994). Cultured lymphocytes at 2 x lO'' 
cells/ml were lysed in PBS-O.5% NP-40 (Sigma) for 30 min on ice with vortexing at 5 min 
intervals to obtain cell lysates. Both supernatant and cell lysates were frozen at -70° C for 
later analysis of granzyme activity. 
Assay for BLT-esterase Activity 
This assay, when compared with the chromium release assay (Towsend and Bodmer. 
1989). gave a correlation coefficient (r") of 0.878 (Suhrbier et al.. 1991). which indicates its 
validity as a reliable cytotoxicity assay. Granzyme-derived enzymatic activity was measured 
using a modification of a previously described procedure (Mobley and Dailey, 1992) by 
adding 40(il of either the cell lysate or the supernatant to 40 |il of the reaction mixture (0.2 M 
Tris-HCl. pH 4.5. 2 •< 10~* M benzyloxycarbonyl-L-lysine thiobenzyl ester (BLT) 
(Calbiochem-Beliring. La Jolla. CA). 2.2 x 10~* M 2-nitro benzoic acid (5, 5'dithiobis. Sigma) 
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in 96-vvell Immulo II microtiter plates (Dynatech, Alexandria. VA) for 15 to 30 min at room 
temperature. The absorbance of the BLT-esterase-induced color change was measured in the 
microplate ELISA reader (BioTek Instruments. Winooski. VT) at a wavelength of405 nm. 
Assay for BAADT-esterase Activity 
Granzyme B-specit'ic enzymatic activity was measured using a modification of a 
previously described procedure (Caputo et al.. 1993) by adding 15 |al of the reaction mixture 
(0.2 mM tert-butyloxycarbonyl-Ala-Ala-Asp-thiobenzyl ester (BAADT) (Enzymes Systems 
Products. Dublin. CA). 0.2 miM Ellman's reagent in buffer A) into 35 |.il of either cell lysate 
or supernatant. Buffer A consists of 0.2 M Hepes (Sigma). 0.2 M NaCl (Fisher Scientific). 
I mM EDTA. 0.05% (v/v) Triton X-100 (Sigma). Ellman's reagent was made by dissolving 
2-nitrobenzoic acid in dimethylsulfoxide (DMSO) (Sigma) at 11 mM. The absorbance of the 
BAADT-aspartase-induced color change was measured in the microplate ELISA reader at a 
wavelength of 405 nm. 
Experimental Design 
From day 0 until the first date of vaccination (d 21) the experimental design was a 
randomized complete block (RCB) with pig within block being die experimental unit for 
dietary treatment. After d 21. the vaccination treatment was added across blocks and the 
design became a split-plot: pig within block being the experimental unit for dietary treatment 
(sub-plot) and a block of two littermate pigs being the experimental unit for vaccination 
treatment (whole plot). 
Statistics 
Data were analyzed as a randomized complete block design from d 0 until d 21. From 
d 21 to the end of the experiment, data were analyzed as a 2 x 2 factorial arrangement of 
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treatments within a split-plot design using the general linear model (GLM) procedure of SAS 
(1989) (SAS Institute Inc.. Cary. NC). 
Results 
Dietary CLA Induces E.xpansion of Peripheral CTLs. NK Cells and TCRySCDSaa Cells 
To determine the effects of dietary CLA supplementation on peripheral CDS* cell 
subsets, tlow cytometric analysis of isolated PBMC was conducted as previously described. 
In pigs, four distinct recirculating CDS'^ cell subsets have been described: TCRySCDSaa. 
CD3"CD16TD8aa (NK cells). TCRapCDSaP (CTLs). and TCRapCD4TD8aa. 
Table 1. Peripheral CDS"^ lymphocyte subset expansion (x lO** cells/ ml blood). 
Vaccination treatments 
NON-VACC. VACC. P values 
Phenotype Day CLA, % 0 1.33 0 1.33 SEM" Vacc Diet VxD 
TCRySCDSaa 50 0.72 0.92 0.90 1.51 0.091 0.05 0.04 0.15 
63 1.07 1.21 1.19 2.21 0.435 0.02 0.02 0.06 
72 1.79 1.61 1.28 1.85 0.293 0.77 0.68 0.42 
TCRapCDSaP 50 1.30 0.99 1.69 2.00 0.177 0.15 0.99 0.22 
63 1.76 2.79 1.58 2.79 0.230 0.80 0.01 0.81 
72 1.92 2.48 1.65 2.61 0.184 0.80 0.02 0.49 
CD3CD8aa' 50 2.25 3.60 2.93 11.50 1.980 0.16 0.12 0.21 
56 2.S2 3.88 2.06 5.19 0.661 0.79 0.06 0.33 
CD16*CD8aa" 72 1.96 2.67 1.00 6.37 0.587 0.16 0.007 0.02 
'Subplot SEM 
''In pigs, both CD3"CD8aa and CD16'^CDSaa include only the NK cell subpopulation. 
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Putatively. there is an additional porcine peripheral CDS" cell subset (TCRapCDSaa) 
whose existence has been reported (Yang and Parhouse. 1996). although, due to the current 
lack of a mAb anti-TCRaP in pigs, there is no direct evidence pointing to the existence of that 
sub-population. 
We showed that CLA synergizes with vaccination to expand the TCRySCDSaa cells 
and NK cell subsets. Dietar\' CLA alone, and not vaccination treatment, expanded the 
TCRapCDSap T cell subset (pre-CTLs) in vivo (Table I). That increase in numbers of CTLs 
was sustained until the end of the experiment (Figure 1). 
Figure 1. Effects of CLA on TCRapCDSaP lymphocytes (CTLs) 
-#-CLA 
-•-No CLA 
Interestingly, the effects of CLA and vaccination on TCRy6CD8aa cells appeared 
earlier (50 to 63 d) than the effects of CLA on pre-CTLs (63 to 72 d). whereas NK cells are 
increased due to CLA and vaccination from d 50 to d 72. In a previous study, the increase in 
CDSa expression appeared at d 42 of dietary CLA supplementation. From d 0 until d 50 no 
differences on CDS" lymphocyte subsets were attributed to dietary CLA supplementation. 
Days of feeding CLA 
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Dietary CLA Supplementation Increases CD8aP but not CD8aa Thymocyte Subsets 
In an effort to determine the origin (thymic or extrathymic) of the peripheral CD8^ 
cell subsets expanded as a consequence of dietary CLA supplementation, thymocytes were 
isolated and their phenotype was analyzed by flow cytometry. Percentages of TCRapCDSap 
thymocytes were increased, but CD8aa" thymocytes were either decreased or unaffected by 
dietary CLA supplementation and by vaccination (Table II). Thus. CTLs are the only CLA-
expanded cell subset with thymic-dependent development. 
Table II. Influence of CLA and vaccination on CDS expression in thymocytes, % 
Vaccination treatments 
NON-VACC. VACC. P value 
Thymocytes CLA, % 0 1.33 0 1.33 SEM" Vacc Diet <
 
X O
 
CDS aa" 58.55 32.15 34.70 36.40 1.626 0.23 0.58 0.32 
CDS ap*-' 8.65 19.15 25.10 32.80 2.475 0.15 0.05 0.06 
CD4 CDS 10.82 9.62 20.85 13.05 0.283 0.03 0.04 0.06 
CD4^ CDS 12.20 10.14 18.60 15.30 0.382 0.05 O . l l  0.41 
CD4^ CDS^(DP) 32.25 30.45 26.50 31.40 0.778 0.24 0.35 0.17 
CD4- CDS (DN)*^ 44.75 49.80 34.10 40.20 0.382 0.05 0.09 0.63 
TCRySCDSaa 2.79 6.24 8.44 2.93 0.488 0.30 0.33 0.08 
''Subplot SEM. 
''Includes CD4CD8 DP. TCRySCDSaa. and putatively TCRapCDSaa thymocytes. 
'"Only includes TCRapCDSaP thymocytes. 
''includes TCRY6CD8aa (dim). TCRapCDSaP (bright), and putatively TCRapCDSaa (dim) 
thymocytes. 
'^CD3"CD4 CD8' are progenitor cells that have migrated from the bone marrow to the thymus. 
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Percentages of TCRySCDSaa thymocytes were neither altered due to dietary CLA 
supplementation nor to vaccination. Percentages of CD4"CD8" thymocytes were not increased 
in response to dietary CLA. but there was a trend towards an increase in CD4"CD8' double 
negative (DN) thymocytes. 
The CLA-induced NK and TCRy5CD8aa Cell Proliferation is Non-specific 
To more fully characterize the nature of the in vivo CLA-induced expansion of CTLs, 
NK cells and TCRy6CD8aa lymphocytes, the proliferative response of the distinct CD8^ cell 
subsets was assessed ex vivo by a proliferation assay coupled to a flow cytometric analysis. 
Briefly. PKH2-stained PBMCs isolated from pigs of four different in vivo treatments (No-
CLA. non-vaccinated: CLA. non-vaccinated: No-CLA. vaccinated: or CLA. vaccinated) were 
cultured with or without antigen (5 ^ g/ml. PD or WCS) or Con-A (5 |ig/ml) for 6 d. and then 
flow cytometrically evaluated for proliferation (Figure 1). 
Table III. Influence of CLA and vaccination on TCRy6CD8aa proliferation, % 
Vaccination Treatments 
NON-VACC. VACC. P value 
TCRy6CD8aa' CLA,% 0 1.33 0 1.33 SEM" Vacc Diet Vx D 
Non-stimulated 4.83 7.26 13.65 15.67 0.358 0.001 0.02 0.62 
WCS-stimulated 
ar> r/-r Uimi-z-i r» - ^ r-» o , 
18.60 24.74 55.62 54.59 14.990 0.15 0.88 0.83 
"PKH2*"'"TCRy5CD8aa lymphocytes are proliferating TCRy8CD8aa. The reason being that, 
as cells divide. PKH2 staining left on the membrane diminishes resulting in a decreased mean 
fluorescence intensity (Ashley et al.. 1993). 
"Subplot SEM. 
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Dietary CLA supplementation and vaccination significantly increased percentages of 
proliferating TCRySCDSaa lymphocytes in non-stimulated wells (Table III) but not in 
antigen- or mitogen-stimulated wells. These results suggest that CLA effects on 
TCRy6CD8aa lymphocytes are non-specific in nature. 
A numerical increase in percentages of proliferating TCRySCDSaa lymphocytes in 
wells stimulated with WCS due to vaccination (Table III), although it is only a statistical 
trend (P<.15). indicates that either the bacterial antigen itself or cytokines produced by 
antigen-specific cells (bystander effect), are involved in TCRySCDSaa lymphocyte 
proliferation in response to vaccination. These results are contirmed by data on thymidine 
incorporation showing that overall mitogen-induced lymphocyte proliferation was enhanced 
in PBMCs from pigs fed CLA regardless of the vaccination treatment. This might be 
explained because CLA decreases PGEi production by interfering with the in vivo synthesis 
of arachidonic acid from linoleic acid. PGEi inhibits lL-2 production and. therefore. T cell 
proliferation (Roitt et al.. 1998). However. WCS-induced proliferation was mainly enhanced 
in pigs fed CLA and vaccinated but not in pigs fed CLA without vaccination (Table IV). 
Table IV. Influence of CLA and vaccination on PBIMC proliferation methyl-[^H| 
thymidine inc., CPM. 
Vaccination Treatments 
NON-VACC. VACC. P value 
Ex vivo treatment CLA, % 0 1.33 0 1.33 SEM^ Vacc Diet Vx D 
Non-stimulated 
WCS-stimulated 
2586 1759 2833 3199 629.3 0.31 0.74 0.44 
2355 1906 4590 20196 1952.3 0.03 0.06 0.05 
Con-A-stimulated 88271 117928 99416 190504 9788.8 0.05 0.02 0.08 
''Subplot SEM 
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Vaccination and CLA Interacted to Increase Percentages of Small Intestinal CD4^CD8aa-
lELs, but not Small or Large Intestinal TCRY6CD8aa-IELs 
Gut associated lymphoid tissue (GALT) is an important source of lymphocytes that 
develop extrathymically. Small cellular clusters called cryptopatches. located within the 
lamina propia of the small intestine, contain T cell progenitors that are CD4'CD8'CD3" c-kit 
positive (c-kit') but lineage marker negative (Lin") (Saito et al.. 1998). These progenitor cells 
are capable of reconstituting peripheral and intestinal T cell compartments upon adoptive 
transfer to immunodetlcient mice (Saito et al.. 1998). Both mice and swine have a greater 
prevalence of CD8'" cells among SMEL and LI-IEL than among LPLs (Camerini et al., 1993). 
To investigate a possible e.xtrathymic origin of peripherally expanded lymphocyte 
subpopulations. we isolated large and small intestine lELs and LPLs. The flow cytometric 
analyisis shows that TCRY6CD8aa-lELs were not significantly increased either in the small 
intestine or in the large intestine because of CLA supplementation (Table V). Therefore, 
CLA-expanded peripheral TCRy5CD8aa T cells 
Table V. Impact of CLA and vaccination in CD8aa expression on GALT lELs, lELs 
Vaccination Treatments 
lELs 
NON-VACC. VACC. 
CLA,% 0 1.33 0 1.33 SEM" Vacc Diet Vx D 
P value 
SI-TCRySCDSaa 
LI-TCRySCDSaa 
SI-CD4^CD8aa 
LI-CDrCD8aa 
8.65 7.74 3.24 14.75 3.097 0.86 0.39 0.34 
8.65 11.75 22.14 5.83 2.475 0.15 0.05 0.06 
1.83 0.81 10.42 14.82 0.I9I 0.16 0.01 0.01 
1.63 1.39 4.93 1.18 l.OIl 0.29 0.17 0.24 
"Subplot SEM 
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cannot be defined as a GALT-originated subset. Nevertheless, percentages of small intestinal 
CD4^CD8aa-lELs were increased when both treatments, vaccination and dietary CLA 
supplementation, were simultaneously administered (Table V). 
Dietary CLA Increases CTL Granzyme Activity Regardless of the Vaccination Treattnent 
To functionally characterize the cytotolvtic activity of PBMC cultured with a bacterial 
antigen (presented through the exogenous pathway) that was previously inoculated to half of 
the pigs, we used the BLT assay. We found that PBMCs isolated from animals fed CLA had 
greater supernatant granzyme activities, after anti-CD3 stimulation, than PBMCs from pigs 
not fed CLA. regardless of the vaccination treatment (Table VI). Anti-CD3 addition to pre-
CTLs causes an increase in cytolytic activity or death via internal action of TNF (Wang et al., 
1994). Thus, either anti-CD3 acted on the naive TCRapCDSaP T cells (pre-CTLs) e.xpanded 
in vivo by dietary CLA supplementation and induced activation and differentiation to CTL. or 
CLA caused a change in expanded pre-CTLs that makes them less prone to undergo anti-
CD3-induced apoptosis. Surv iving effector CTLs will release the 
Table VI. Influence of CLA on peripheral TCRapCDSaP granzyme activity, OD 
Vaccination Treatments 
NON-VACC. VACC. P value 
Granzyme activity CLA, % 0 1.33 0 1.33 SEM" Vacc Diet VxD 
BLT PD-stim. (supernatant) 0.178 0.213 0.191 0.205 0.002 0.46 0.005 0.11 
BAADT ConA-stim. (supernatant) 0.081 0.087 0.084 0.096 0.002 0.21 0.11 0.40 
BLT PD-stim. (ccil lysate) 0.062 0.074 
Jo I. I . OI-» ^ 
0.062 0.060 0.001 0.03 0.05 0.02 
"Subplot SEM 
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content of lytic granules (e.g.. perforin, granzymes) into the media. NK cells do not express 
TCR/CD3 complex on their surface, thus anti-CD3-induced degranulation is not NK-derived. 
NK-derived granzyme activity, if any. will only result from a constitutive release of 
granzyme. Thus, granzyme activity in the supernatant harvested after anti-CD3 addition is 
mainly derived from effector CTLs. These results also indicate that, even when CLA 
increases pre-CTL production, it is not decreasing their potential to develop cytolytic activity. 
Table VII. Influence of CLA and vaccination on CD4^CD8' proliferation, %. 
Vaccination Treatments 
NON-VACC. VACC. P value 
CD4"CD8* CLA,% 0 133 0 1.33 SEM" Vacc Diet Vx D 
Non-stimulated 9l2 9779 13.05 22.90 1588 0.08 0.17 0.21 
WCS-stimulated 22.02 27.27 40.19 78.77 5.268 0.02 0.05 0.08 
PD-stimulatcd 32.36 36.80 42.72 62.14 5.954 0.09 0.18 0.33 
Con-A-stimulatcd 88.71 85.92 94.68 96.15 1.690 0.04 0.73 0.33 
'Subplot SEM 
Discussion 
Here, we report a new method, different from the traditional antigen-induced clonal 
selection, to expand in vivo particular peripheral CD8" lymphocyte subsets, which consists of 
feeding a mixture of positional and geometric isomers of conjugated octadecadienoic acid. 
We demonstrate that CLA expands pre-CTLs. NK cells and TCRy8CD8aa lymphocytes in 
pigs in a non-specific fashion. Interestingly, in vivo expansion of pre-CTLs is independent of 
the vaccination, whereas NK cell and TCRY6CD8aa CLA-induced expansion is either 
enhanced by vaccination or CLA turther enhances the proliferation of cell subsets expanded 
by vaccination with a bacterial antigen. That expansion of particular CD8^ lymphocyte 
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subsets is correlated with increased WBC counts. The CLA-enhanced WBC counts are due to 
elevated lymphocyte numbers (data not shown) and not to an increase in polymorphonuclear 
cells. This finding is consistent with earlier work conducted by Cook et al. (1998). 
Bacterial antigens, such as other extracellular antigens, follow the exogenous pathway 
of antigen presentation to the MHC class II (SLA complex class 11. in pigs). They are known 
to induce clonal selection of CD4'^ cells. In the case of the B. hyodysenteriae proteinase-
digested bacterin. that T helper enhancement occurs along with enhanced proliferation of 
CD8aa' cell subsets, that it is possibly cytokine-driven. Proliferation assays confirmed that 
the bacterial antigen used here induces proliferation of CD4' cells (Table VII). CLA seems to 
potentiate this effect on CD4' cells, but a CLA-dependent CD4' expansion was not measured 
in vivo. This finding is consistent with our findings regarding B. hyodysenterkie-s^cc\{\c 
proliferation, indicating that depletion ofCD4' cells inhibits overall proliferation (data not 
shown). Even in the face of an ongoing immune response that targets CD4" cells induced by 
spirochetal antigens. CLA alone still increases pre-CTLs. a CDS'^ cell subset that is not 
affected by the bacterial antigen and would only be affected by non-self antigens presented 
through the endogenous pathway. CLA is capable of non-specifically expanding immature 
thymocytes with CTL phenotype. pre-CTL numbers and CTL activity. Therefore, based on 
these findings, dietary CLA could improve the efficacy of infectious and autologous 
vaccination protocols in which particular CDS'" cell subsets are critical for effective immune 
protection. In contrast to the specific nature of both CTL e.xpansion caused by an intracellular 
antigen or of CD4 expansion caused by an extracellular antigen. CLA-induced expansion of 
CD8^ lymphocyte subsets must occur through increased lymphocyte production and not 
through clonal selection. Aiming to elucidate which lymphoid tissue containing pre-CTLs or 
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pre-CTL precursors received the greatest impact from CLA. we measured both peripheral and 
thymic lymphocyte phenotypes. The basis for a non-clonally-derived e.xpansion of T cell 
subsets can be partly found in the thymus and partly in the bone marrow, whereas the basis 
for NK cell expansion is presumably bone marrow related. The increase in TCRapCDSap 
thymocytes might be related to greater numbers of progenitor cells (DN thymocytes) in pigs 
fed CLA. DN thymocytes that have migrated from the bone marrow to the thymus, after 
positive and negative selection, and a process of lineage choice, will be released into the 
circulation (Janeway. 1999). As CLA has a strong influence on progenitor T cells, in contrast 
to what would happen upon antigen-specific stimulation that affects mature lymphocytes. 
CLA should maintain the diversity of the TCR repertoire in peripheral naive pre-CTLs and 
TCRy6CD8aa cells. Furthermore, the influence of CLA on progenitor cells is possibly 
originated in the bone marrow, which is the tissue with the highest concentration of CLA c-9, 
t-11/1-9. c-11 isomers in rats (Li et al.. 1998). A bone marrow effect of CLA is also supported 
by the increased percentages of peripheral mononuclear cells. And because the effect of CLA 
is focused on mononuclear cells. CLA might be targeting a lymphoid precursor population. 
Kondo et al. (1997) recently described a lymphoid precursor population lacking myeloid 
differentiation potential, which phenotypically is LinlL-TR'Thy'Sca'^CDl 17'°. [f the in vivo 
expansion of peripheral T cell subsets has originated in the bone marrow and CLA is having 
the greatest impact on a lymphoid precursor population that could explain the increased 
numbers of progenitor cells in the thymus. 
The peripheral expansion of pre-CTLs induced by CLA is of particular interest to us 
for three reasons: firstly, it shows that pre-CTLs are non-specifically expanded by a nutrient 
for several weeks. The expansion of that cell subset, being non-specific and having its origin 
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in progenitor cells and not on mature lymphocytes, would maintain the diversity of the T cell 
repertoire, secondly, because the e.xpansion of peripheral pre-CTLs is linked to an increase of 
bone marrow-originated DN cells and subsequently of CDSaP^ thymocytes, which suggest an 
effect of CLA on primary lymphoid organs, and. finally, because that modulation in CD8^ 
cell subset phenotype caused by dietary CLA can be functionally linked to an enhancement in 
cytotoxicity. From a functional perspective, we found that PBMCs isolated from animals fed 
CLA. after anti-CD3 stimulation, had greater supernatant granzyme activities than did 
PBMCs from pigs not fed CLA. regardless of the vaccination u-eatment. Our ex vivo finding 
on cytotoxicity is consistent with in viu^o data (Chew et al.. 1997) indicating that lymphocyte 
cytotoxicity was enhanced by CLA addition into the cell culture. Anti-CD3 addition to pre-
CTLs causes an increase in cytolytic activity or death via internal action of TNF (Wang et al.. 
1994). Thus, either anti-CD3 acts on the peripheral naive TCRapCDSap T cells (pre-CTLs) 
expanded in vivo by dietary CLA supplementation and induces activation and differentiation 
to CTL and degranulation. or CLA causes a change in expanded pre-CTLs that renders them 
less prone to undergo anti-CD3-induced apoptosis. Activated effector TCRapCDSaP T cells 
and NK cells are granzyme producers and are involved in inducing apoptosis of target cells 
presenting foreign epitopes presented to MHC class I (SLA complex class 1. in pigs) through 
the endogenous pathway of antigen presentation. Thus, they are involved in antiviral immune 
responses and in tumor surveillance. 
Altliough the composition of the CD8^ lymphocyte population differs between animal 
species, a flmctional convergence across species appears at the molecular level. Structurally, 
the cytoplasmic domain of the CD8a chain is non-covalently associated to the cytoplasmic 
tyrosine kinase p56''^'' (Sun et al.. 1997), which suggests an involvement of CDSa in signal 
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transduction events. On tiie otiier hand, the likelihood for a role of the CDSp chain 
cytoplasmic domain in signal transduction seemed to be very low based on its length of only 
19 amino acids and also considering that no protein binding motif has been identified within 
that amino acid sequence. However, the lack of the 19 amino acid cytoplasmic domain in 
CDSp chains interferes with the development of mature CDS T cells (Itano et al., 1994). They 
also described that different class 1-restricted TCRs differ in their dependence on the CDSp 
cytoplasmic tail. Recently, it has been suggested (Levelt et al.. 1999) that the CDSp chain 
increases the sensitivity of the TCR by enhancing recruitment of p56'''^'' to the alpha chain. 
Thus, both CD8a and CD8p chains play important roles in thymocyte development and 
activation of mature T cells. An important consequence of CD8aP co-stimulation in the 
context of appropriate TCR/CD3 stimulus is degranulation of lytic granules, which play an 
important role in the destruction of target cells by effector CTLs. 
NK cells are a part of the innate immunity and do not e.xpress the TCR/CD3 complex 
on their surface. Besides, thymic NK activity has not been described in pigs (Pinto and 
Ferguson. 1988). Therefore. NK cells are released from the bone marrow into the 
bloodstream together with immature precursors of T cells and B cells, but do not undergo 
positive and negative thymic selection. A direct effect of CLA on bone marrow precursors of 
CDS' lymphocytes would explain the increased numbers of NK cells and pre-CTLs in blood, 
and the increased percentages of CDSaP^ cells in the thymus. With regard to the effects of a 
bacterial antigen challenge in expanding NK cells and y6 T cells, it is interesting to note that 
NK cells are known not to be antigen specific, and yS T cells recognize antigen in a different 
way than ap T cells. Therefore, the mechanism by which a bacterial antigen expands these 
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two cell subsets remains unclear. A possible explanation is that NK cell subset expansion is a 
cytokine-driven phenomenon. Also, the impact of particular bacterial components, such as 
bacterial lipoproteins (BLPs). in regulating the innate immune response through NF-kB-
activation and cytokine production (Aliprantis et al.. 1999) could potentially influence 
peripheral NK cell numbers. There are no reports either confirming or denying the existence 
B. hyodysemeriae-dcvw^d BLPs. However. Borrelia burgdorferi like B. hyodysenteriae is a 
spirochete but. in the case of the causative agent of Lyme disease. BLPs have been identified 
that stimulate a type of immune response involving y8 T cells (Vincent et al.. 1998). Also a 
lipoprotein lipase is expressed in NK cells and plays a role in their cytotoxic activity (Sanctis 
et al.. 1994). We showed that CLA synergizes with vaccination to expand TCRySCDSaa 
cells and NK cells. Thus, the effect of a spirochetal antigen on NK cells and y5 T cells 
expansion could be explained through the influence of BLPs on innate immunity. In that case, 
a lipase-digested compared with the a proteinase-digested B. hyodysenteriae vaccine 
preparation will help understand the effects of BLPs on cellular immunity. 
Most yo T cells are thymus-dependent. but a small population of thymus-independent 
y6 T cells, was followed for 2 years after thymectomy (Licence et al.. 1995). which indicates 
the existence of a thymus-independent y6 T cell subset. Based on those ontogenic findings, 
the origin of the peripheral CLA-induced expansion of the TCRy6CD8aa cell subset. 
theoretically, can be explained in two different ways; either the CLA-induced increase in 
TCRy6CD8aa cells has a thymic origin or an extra-thymic origin. A thymic origin of that 
peripheral y6 T cell subset is not supported by our data, because TCRy6CD8aa thymocytes 
were not influenced by dietary CLA supplementation. y5 thymocyte development differs from 
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that on aP thymocytes in the major proliferation of double negative thymocytes into 
CD4CD8 DP immature thymocytes, that are then subject to positive and negative selection, 
and the process of lineage {CD4 versus CDS) choice (Janevvay. 1999). We have shown 
increased DN thymocyte subsets but not in TCRySCDSaa thymocytes. It is possible that a 
greater a(3 thymocyte proliferation might have masked the effects of CLA on y6 thymocytes. 
The second way to explain why peripheral TCRy5CD8aa cell subsets were expanded but not 
thymic CD8aa" cells is considering an extra-thymic origin of CLA-expanded TCRy5CD8aa 
lymphocytes. .A. GALT origin of that cell subset cannot be supported by the phenotypic 
profiles of lELs and LPLs. which indicate that TCRy6CD8aa cells were not increased 
because of dietary CLA supplementation. An extrathymic and GALT-dependent origin could 
be explained assuming that some of the TCRy6CD8aa lymphocytes originated in the GALT 
migrated to the periphery. .An extrathymic and GALT-independent origin possibly implies 
other MALT such as BALT and CALT in the production of that peripheral cell subset. 
In summary. CLA is a complex nutrient that strongly influences phenotype and 
function of the distinct CD8^ lymphocyte subsets. The knowledge of the impact of CLA on 
NK cells. TCRy6CD8aa cells and CTLs will have important applications in both research on 
the biology of CD8" cells and. clinically, as a nutritional enhancer of CDS'" cells that could be 
used either as a complement for infectious or tumoral vaccination protocols, which might be 
particularly useful in patients with a suppressed cellular immunity. CLA could have an 
influence in most assays of cellular immunity involving utilization of fetal calf serum. 
because CLA represents between .5 and .9 % of fatty acids contained in fetal calf serum 
(Park. 1996). Of particular interest is that CLA. a compound of known anticarcinogenic 
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activity, increases two of tiie cell subsets that perform crucial roles in tumor surveillance. The 
link between the anticarcinogenic and the immunomodulating properties of CLA was ruled 
out by Vissonneau et al. (1997) when they showed that CLA was anticarcinogenic in SCID 
mice. However, they did not use normal mice as controls to see if tumor growth inhibition 
was greater with normal mice fed CLA than in SCID mice fed CLA. Thus, they showed that 
there is a mechanism of anticarcinogenicity that is non-immune related, but they did not 
provide proofs capable of negating that there is indeed an immune-related mechanism. 
Several experiments relate CTLs and tumor regression. For instance, in mice, migration of 
CD8" T cells into ovarian carcinomas and melanomas was associated with tumor regression 
(Ogawa et al.. 1997). in humans receiving hapten-modified autologous tumor cell vaccines, 
lymphocytic infiltrates within regressing melanoma metastases are primarily comprised of 
CD8' cells (Sensi et al.. 1997). In humans with AIDS, autologous CD8^ T cells activated with 
lL-2 play an important role in causing regression of Kaposi's sarcoma lesions (Klimas et al.. 
1994). In mice. CDS' T cells are mediators of the anti-leukemic effects of IL-2 (Yang et al.. 
1997). The demonstration of CLA involvement in in vivo expansion of cell subsets utilized in 
tumor surveillance (CTLs and NK cells) should be considered as a possible cellular basis of 
the mechanism of action of CLA as an anticarcinogen. Chew et al. (1997) indicated that the 
anticarcinogenic activity of CLA could be mediated through an enhancement of immune 
function based on in vitro data. Here we provide phenotypic and functional in vivo data lo 
further support the theory that the anticarcinogenic effects of CLA are mediated by a 
modulation of immune cell phenotype and immune response. 
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Figure I. Effect of CLA and vaccination on TCRy6CD8aa subset proliferation 
PBMCs from no CLA/non-vaccinated. CLA/non-vaccinated. no CLA/ vaccinated, and 
CLA/vaccinated pigs were stained with PKH2 and cultured with or without a WCS B. 
hyociysenteriae antigen. At d 6. cells were harvested and assayed for CD8a and TCRyS 
surface expression. Non-viable cells were excluded using viability probes (not shown). The 
TCRySCDSaa subpopulation within the cell viable gate (R2) was analyzed for PKH2 
fluorescence intensity. M2 represents TCRy6CD8aaPKH2''"" cells (proliferative fraction). 
141 
CHAPTER 4, GENERAL CONCLUSIONS 
General Discussion 
Nutrition, along with disease status, genetics and management practices are the four 
key factors that determine the productivity of livestock operations. For a long time, a greater 
productivity was achieved by dietary antimicrobial supplementation at sub-therapeutical 
levels. Consumers in Europe and United States demand the suppression of the latter practice. 
Alternatives to the use of anti-microbials that are appealing to consumers should be able to 
be characterized as safe, natural products with broad biological activity that can be 
supplemented into dietarv' formulations, and that are lacked of antimicrobial connotations in 
their label. CLA can be included in that categorization and. therefore, could be considered as 
a possible consumer-accepted alternative to the use of antimicrobials. 
I have described the effects of CLA on growth performance and body composition. In 
my first e.xperiment. 1 showed that, as the percentage of CLA in the diet increased there was 
a decrease in body fat (P<.07) and. in phase II. pigs fed CLA had a linear increase in ADG 
(P<.05) and .ADFl (P<.02). However, the focus of my dissertation, is on the cellular 
immunomodulation induced by dietary CLA supplementation, which 1 have demonstrated for 
the first time. 
.My experimental work has described the impact that CLA has on cell-mediated 
immunity in swine. As a result of my investigations, we know which lymphocyte 
subpopulations are increased as a result of dietary CLA supplementation (NK cells. CTLs 
and TCRy6CD8aa cells). 1 have also developed the metliodology and assays to evaluate the 
interactions between CLA and a swine dysentery vaccine at the cellular level, which could be 
easily applied to analyze the interactions with either vaccines against other infectious agents 
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or tumor vaccines. In the case of the swine dysentery vaccine. I have demonstrated that NK 
cells and TCRy6CD8aa cell subsets are in vivo expanded by vaccination. Therefore, I have 
further characterized the immunological response to this vaccine. All that has been done in 
the conte.xt of enhancing the understanding of porcine immunology and of how nutrition 
modulates immune function. 
In summary. I initiated my research with the purpose of developing a nutritional 
technology capable of enhancing the health status in swine, therefore, the purpose was 
agricultural in origin. However, in the light of the importance of the fmdings described here, 
multiple non-agricultural applications could be derived from the better understanding of the 
role of CLA in cellular immunity e.g., dietary supplement for immunosuppressed humans or 
companion animals: nutritional complement for certain vaccination protocols involving 
induction of CDS'" cells; technology to increase the peripheral lymphocyte pool in HIV^ 
humans; etc. 
Recommendations for Future Research 
The next step for this research would be to evaluate the cell populations most affected 
by CLA at a molecular level. A possible option to accomplish that objective would be to 
measure the impact of CLA on PPARs e.xpressed in CDS" subpopulations. In the light of the 
results of my research linking CLA and CDS" cells, and considering the importance that 
PPARs might have in explaining that link, future experiments should be designed to better 
understand the role of PPARs in cellular immunology, and particularly, how CD8^ cells are 
regulated by PPARs. A possible approach to answer these questions would be to use murine 
models with altered PPAR expression, e.g. transgenic mice expressing high levels of PPAR-y 
and PPAR-y knockout mice might be good models to study how CD8^ cell phenotype and 
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function are linked to this orphan receptor. Genetically modified murine models could 
provide valuable hints with regard to the consequences of CLA-PPARs ligation on gene 
expression and on immune cell phenotype and immune response. 
PPAR-y ligands have been proposed as key elements for a novel therapy for 
inflammatory bowel disease (IBD) in humans. Research analyzing the relationship between 
CLA and gastrointestinal health could provide data indicating the potential utilization of 
CLA as an anti-inflammatory natural product that enhances gastrointestinal health and 
function. The potential for application of this nutritional anti-inflammatory technology is 
enormous in both animal agriculture (livestock gastrointestinal inflammatory diseases like 
swine dysentery) and human medicine (IBD). Individual isomers of CLA should be tested for 
their binding affinity to distinct PPAR. 
From a whole animal perspective, no empirical evidences denying or suggesting an 
interaction between CLA and vitamin A are available. However the relationship between 
PPAR and retinoic acid receptors, described at the cellular level (Table 5) suggest that an 
interaction could occur. The development of a product consisting of a mixture of CLA or 
specific CLA isomers and vitamin A or specific vitamin A derivatives could potentially 
become a powerful modulator of cellular immunity. 
The CLA-induced e.xpansion of CTLs and NK cells, both involved in anti-tumor and 
anti-viral activities, could provide the cellular basis for the anticarginogenic properties of 
CLA. Future studies should analyze the efficacy of the CLA-induced changes in cellular 
immunity in inhibiting neoplasia formation, enhancing neoplasia regression and in enhancing 
the efficacy of vaccines developed against viruses. 
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Finally, other fatty acids might have similar properties than CLA. The identification 
of these fatty acids could uncover unknown sources of broad biological like CLA. Based on 
the fact that some conjugated linolenic acids (CLnA) (e.g.. a-eleostearic acid, punicic acid, 
a-parinaric acid), regardless of the configuration of the third double bond, have two double 
bonds in the cis-9. trans-11 positions, the CLA isomer that is most abundant in the bone 
marrow, might indicate the need to further characterize the biological effects of CLnA. These 
conjugated trienes. similarly to what CLA does in cancer prevention, decreased the 
development of chemically-induced cancer (Jacobson. 1953), also, similarly to the effects of 
CLA in feed intake in laboratory animals, tung oil (a source of CLnA) suppressed food intake 
in rats (McPherson et al.. 1973). If conjugated uienes are PPAR ligands. additional research 
looking at the interaction with vitamin A would also be required. 
Although the main focus of this dissertation was CLA. the utilization of a spirochetal 
vaccine to measure antigen-specific responses permitted a better understanding of the effects 
of this vaccine on cellular immunity. Based on our findings, a future research on swine 
dysentery vaccine development should evaluate separately the effects of the vaccine on NK 
cells and TCRyoCDSaa cells, which are potentially induced by bacterial lipoproteins and the 
effects on other T cell subsets that would be induced by the peptides found in the proteinase-
digested vaccine. A lipase-digestion of the bacterial preparation could potentially avoid the 
effects of vaccination on innate immunity and facilitate the understanding of its effects on 
adaptative immunity. Furthermore, the identification of large intestine bacteria that might 
contribute to the pathogenesis of the disease, and the development of vaccines with antigens 
from these bacteria should also be considered as a means to enhance vaccine efficacy. 
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